DSS (DSS) 10-K 6 Mar 18 2017 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2017	Mar. 01, 2018	Jun. 30, 2017
Document And Entity Information
Entity Registrant Name	DOCUMENT SECURITY SYSTEMS INC
Entity Central Index Key	771,999
Document Type	10-K
Document Period End Date	Dec. 31, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity a Well-known Seasoned Issuer	No
Entity a Voluntary Filer	No
Entity's Reporting Status Current	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 9,498,688
Entity Common Stock, Shares Outstanding		16,599,327
Trading Symbol	DSS
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,017

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Current assets:
Cash	$ 4,188,623	$ 5,871,738
Restricted cash	256,005	177,609
Accounts receivable, net	2,025,284	1,890,981
Inventory	1,651,246	1,206,377
Prepaid expenses and other current assets	261,324	350,289
Total current assets	8,382,482	9,496,994
Property, plant and equipment, net	4,805,640	4,573,841
Investment	484,930
Other assets	83,376	45,821
Goodwill	2,453,597	2,453,349
Other intangible assets, net	1,220,752	1,896,018
Total assets	17,430,777	18,466,023
Current liabilities:
Accounts payable	728,652	2,212,653
Accrued expenses and deferred revenue	1,105,718	1,290,593
Other current liabilities	2,953,629	2,996,310
Short-term debt	3,645,760
Current portion of long-term debt, net	966,506	1,202,335
Total current liabilities	9,400,265	7,701,891
Long-term debt, net	1,734,171	5,249,569
Other long-term liabilities	1,384,500	2,184,843
Deferred tax liability, net	125,982	45,619
Commitments and contingencies (Note 12)
Stockholders' equity
Common stock, $.02 par value; 200,000,000 shares authorized, 16,599,327 shares issued and outstanding (13,502,653 on December 31, 2016)	331,987	270,053
Additional paid-in capital	106,633,708	104,338,002
Subscription receivable	(300,000)
Accumulated other comprehensive loss	(23,069)	(45,343)
Accumulated deficit	(101,856,767)	(101,278,611)
Total stockholders' equity	4,785,859	3,284,101
Total liabilities and stockholders' equity	$ 17,430,777	$ 18,466,023

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Common stock, par value	$ .02	$ .02
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	16,599,327	13,502,653
Common stock, shares outstanding	16,599,327	13,502,653

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Revenue:
Printed products	$ 17,026,247	$ 17,277,172
Technology sales, services and licensing	1,635,625	1,900,427
Total revenue	18,661,872	19,177,599
Costs and expenses:
Cost of revenue, exclusive of depreciation and amortization	11,008,882	11,119,780
Selling, general and administrative (including stock based compensation)	6,465,016	7,326,063
Depreciation and amortization	1,413,838	1,391,815
Total costs and expenses	18,887,736	19,837,658
Operating loss	(225,864)	(660,059)
Other income (expense):
Interest income	4,209
Interest expense	(223,321)	(248,064)
Amortized debt discount	(154,142)	(31,150)
Loss before income taxes	(599,118)	(939,273)
Income tax expense (benefit)	(20,962)	10,730
Net loss	(578,156)	(950,003)
Other comprehensive loss:
Interest rate swap gain	22,274	18,354
Comprehensive loss:	$ (555,882)	$ (931,649)
Loss per common share:
Basic and diluted	$ (0.04)	$ (0.07)
Shares used in computing loss per common share:
Basic and diluted	14,424,344	13,068,329

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash flows from operating activities:
Net loss	$ (578,156)	$ (950,003)
Adjustments to reconcile net loss to net cash (used by) from operating activities:
Depreciation and amortization	1,413,838	1,391,815
Stock based compensation	214,862	328,567
Paid in-kind interest	72,000	39,000
Change in deferred tax provision	80,363	(116,488)
Amortization of deferred financing costs	154,142	21,351
Gain on settlement of legal expenses	(219,364)
Decrease (increase) in assets:
Accounts receivable	(134,303)	206,452
Inventory	(444,869)	(268,547)
Prepaid expenses and other current assets	51,409	(38,532)
Restricted cash	(78,396)	115,434
Increase (decrease) in liabilities:
Accounts payable	(893,431)	267,581
Accrued expenses	(60,791)
Other liabilities	(944,834)	4,469,895
Net cash (used by) from operating activities	(1,367,530)	5,466,525
Cash flows from investing activities:
Purchase of property, plant and equipment	(958,819)	(269,870)
Proceeds from sale of intangibles		495,000
Purchase of intangible assets	(11,552)	(73,661)
Net cash (used by) from investing activities	(970,371)	151,469
Cash flows from financing activities:
Payments of long-term debt	(818,332)	(1,386,420)
Borrowings from equipment line of credit	522,000
Issuances of common stock, net of issuance costs	951,118	199,908
Net cash from (used by) financing activities	654,786	(1,186,512)
Net (decrease) increase in cash	(1,683,115)	4,431,482
Cash at beginning of year	5,871,738	1,440,256
Cash at end of year	$ 4,188,623	$ 5,871,738

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Common Stock [Member]	Additional Paid-In Capital [Member]	Subscription Receivable [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2015	$ 259,410	$ 103,820,170		$ (63,697)	$ (100,328,608)	$ 3,687,275
Balance, shares at Dec. 31, 2015	12,970,487
Issuance of common stock, net	$ 6,000	193,908				199,908
Issuance of common stock, net, shares	300,000
Stock based payments, net of tax effect	$ 4,620	323,947				328,567
Stock based payments, net of tax effect, shares	231,000
Shares issued upon reverse stock split as a result of rounding up of fractional shares	$ 23	(23)
Shares issued upon reverse stock split as a result of rounding up of fractional shares, Shares	1,166
Other comprehensive gain				18,354		18,354
Net Loss					(950,003)	(950,003)
Balance at Dec. 31, 2016	$ 270,053	104,338,002		(45,343)	(101,278,611)	3,284,101
Balance, shares at Dec. 31, 2016	13,502,653
Issuance of common stock, net	$ 58,934	2,083,844	(300,000)			1,842,778
Issuance of common stock, net, shares	2,946,674
Stock based payments, net of tax effect	$ 3,000	211,862				214,862
Stock based payments, net of tax effect, shares	150,000
Other comprehensive gain				22,274		22,274
Net Loss					(578,156)	(578,156)
Balance at Dec. 31, 2017	$ 331,987	$ 106,633,708	$ (300,000)	$ (23,069)	$ (101,856,767)	$ 4,785,859
Balance, shares at Dec. 31, 2017	16,599,327

Description of Business

Description of Business	12 Months Ended
	Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	NOTE 1 - DESCRIPTION OF BUSINESS Document Security Systems, Inc. (the “Company”), through two of its subsidiaries, Premier Packaging Corporation, which operates under the assumed name of DSS Packaging Group, and Plastic Printing Professionals, Inc., which operates under the name of DSS Plastics Group, operates in the security and commercial printing, packaging and plastic ID markets. The Company develops, markets, manufactures and sells paper and plastic products designed to protect valuable information from unauthorized scanning, copying, and digital imaging. The Company’s subsidiary, DSS Digital Inc., which also operates under the name of DSS Digital Group, develops, markets and sells digital information services, including data hosting, disaster recovery and data back-up and security services. The Company’s subsidiary, DSS Technology Management, Inc., manages, licenses and acquires intellectual property (“IP”) assets for the purpose of monetizing these assets through a variety of value-enhancing initiatives, including, but not limited to, investments in the development and commercialization of patented technologies, licensing, strategic partnerships and commercial litigation.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation Use of Estimates Reclassifications Restricted Cash Accounts Receivable Inventory Property, Plant and Equipment Investment Goodwill - Other Intangible Assets and Patent Application Costs Impairment of Long Lived Assets Fair Value of Financial Instruments ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The carrying amounts reported in the balance sheet of cash, accounts receivable, prepaids, accounts payable and accrued expenses approximate fair value because of the immediate or short-term maturity of these financial instruments. The fair value of revolving credit lines, notes payable and long-term debt approximates their carrying value as the stated or discounted rates of the debt reflect recent market conditions. Derivative instruments, as discussed below, are recorded as assets and liabilities at estimated fair value based on available market information. The fair value of investments carried at cost is estimated to exceed carrying value; however the fair value is not considered readily determinable based on the lack of liquidity for the shares owned. Derivative Instruments . As of December 31, 2017 the Company has an interest rate swap agreement for its debt with RBS Citizens, N.A. (“Citizens Bank”) (see Note 7) which changes a variable rate into a fixed rate on a term loan as follows: Notional Amount Variable Rate Fixed Cost Maturity Date $ 915,107 4.512 % 5.87 % August 30, 2021 Share-Based Payments Revenue Recognition For technology sales and services, revenue is recognized in accordance with FASB ASC 985-605. Accordingly, revenue is recognized when all of the following conditions are satisfied: (1) there is persuasive evidence of an arrangement; (2) the service or product has been provided to the customer; (3) the amount of fees to be paid by the customer is fixed or determinable; and (4) the collection of our fees is reasonably assured. We recognize cloud computing revenue, including data backup, recovery and security services, on a monthly basis, beginning on the date the customer commences use of our services. Professional services are recognized in the period services are provided. For printing technology licenses, revenue is recognized once all the following criteria for revenue recognition have been met: (1) persuasive evidence of an agreement exists; (2) the right and ability to use the product or technology has been rendered; (3) the fee is fixed and determinable and not subject to refund or adjustment; and (4) collection of the amounts due is reasonably assured. For other technology licenses, revenue arrangements generally provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional payment. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on the Company’s part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectability is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met. Certain of the Company’s revenue arrangements provide for future royalties or additional required payments based on future licensee activities. Additional royalties are recognized in revenue upon resolution of the related contingency provided that all revenue recognition criteria, as described above, have been met. Amounts of additional royalties due under these license agreements, if any, cannot be reasonably estimated by management. Costs of revenue - Contingent Legal Expenses - Advertising Costs . Research and Development Income Taxes Earnings Per Common Share As of December 31, 2017 and 2016, there were 3,177,759 and 3,672,878, respectively, of common stock share equivalents potentially issuable under convertible debt agreements, employment agreements, options, warrants, and restricted stock agreements that could potentially dilute basic earnings per share in the future. Common stock equivalents were excluded from the calculation of diluted earnings per share for 2017 and 2016 in which the Company had a net loss, since their inclusion would have been anti-dilutive. Comprehensive Loss Concentration of Credit Risk During 2017, two customers accounted for 46% of our consolidated revenue. As of December 31, 2017, these two customers accounted for 38% of our trade accounts receivable balance. During 2016, these two customers accounted for 38% of our consolidated revenue. As of December 31, 2016, these two customers accounted for 31% of our trade accounts receivable balance. Recent Accounting Pronouncements In January 2016, the FASB issued ASU 2016-01, “Recognition and Measurement of Financial Assets and Financial Liabilities”, which requires that most equity investments be measured at fair value, with subsequent changes in fair value recognized in net income. Entities will no longer be able to use the cost method of accounting for equity securities. However, for equity investments without readily determinable fair values, entities may elect a measurement alternative that will allow those investments to be recorded at cost, less impairment, and adjusted for subsequent observable price changes. The pronouncement also impacts financial liabilities under the fair value option and the presentation and disclosure requirements for financial instruments. This pronouncement is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017, and early adoption is not permitted. The Company is currently assessing the impact that adopting this new accounting standard will have on our Consolidated Financial Statements. In February 2016, the FASB issued ASU 2016-02, “Leases”, which requires that lease arrangements longer than 12 months result in an entity recognizing an asset and liability. ASU 2016-02 is effective for interim and annual periods beginning after December 15, 2018, and early adoption is permitted. The Company has not yet evaluated nor has it determined the effect of the standard will have on its consolidated financial statements and related disclosures. In August 2016, the FASB issued ASU 2016-15, “Classification of Certain Cash Receipts and Cash Payments”, which clarifies the treatment of several types of cash receipts and payments for which there was diversity in practice. This update is effective for annual periods beginning after December 15, 2017, and interim periods within those fiscal years, with early adoption permitted, including adoption in an interim period. We anticipate that the adoption of this guidance will not have a material impact on our consolidated financial statements. In November 2016, the FASB issued ASU 2016-18, “Statement of Cash Flows”, regarding the presentation of restricted cash on the statement of cash flows. The standards update requires that the reconciliation of the beginning and end of period cash amounts shown in the statement of cash flows include restricted cash. When restricted cash is presented separately from cash and cash equivalents on the balance sheet, a reconciliation is required between the amounts presented on the statement of cash flows and the balance sheet. Also, the new guidance requires the disclosure of information about the nature of the restrictions. The standards update is effective retrospectively for fiscal years and interim periods beginning after December 15, 2017, with early adoption permitted. In January 2017, the FASB issued ASU 2017-04, “Intangibles – Goodwill and Other (Topic 350) – Simplifying the Test for Goodwill Impairment”, which eliminates the two-step process that required identification of potential impairment and a separate measure of the actual impairment. The annual assessment of goodwill impairment will be determined by using the difference between the carrying amount and the fair value of the reporting unit. The standards update are effective for goodwill impairment tests in fiscal years beginning after December 15, 2019. The Company is currently assessing the impact that adopting this new accounting standard will have on our Consolidated Financial Statements. In May 2017, the FASB issued ASU 2017-09, “Compensation – Stock Compensation (Topic 718) – Scope of Modification Accounting”, which provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. ASU 2017-09 is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, and early adoption is permitted, including in an interim period. ASU 2017-09 is to be applied on a prospective basis to an award modified on or after the adoption date. We do not intend to early adopt ASU 2017-09 and do not expect the adoption of this new accounting standard will have a material impact on our Consolidated Financial Statements. In February 2018, the FASB issued ASU 2018-03, “Technical Corrections and Improvements to Financial Instruments (Subtopic 825-10) – Recognition and Measurement of Financial Assets and Financial Liabilities”. This update was issued to clarify certain narrow aspects of guidance concerning the recognition of financial assets and liabilities established in ASU No. 2016-01, “ ”. Newly Adopted Accounting Pronouncements In March 2016, the FASB issued ASU 2016-09, “Compensation — Stock Compensation: Improvements to Employee Share-Based Payment Accounting.” The standard is intended to simplify several areas of accounting for share-based compensation arrangements, including the income tax impact, classification on the statement of cash flows and forfeitures. ASU 2016-09 was effective for the Company as of January 1, 2017. Adoption of this new accounting standard resulted in the recognition of an increase in the Company’s gross deferred tax asset of approximately $350,000 and an offsetting increase in the valuation allowance. There was no impact to the Company’s retained earnings or other material impact to the financial statements as a result of adopting this new accounting standard.

Inventory

Inventory	12 Months Ended
	Dec. 31, 2017
Inventory Disclosure [Abstract]
Inventory	NOTE 3 – INVENTORY Inventory consisted of the following at December 31: 2017 2016 Finished Goods $ 965,757 $ 736,987 Work in process 383,270 314,353 Raw Materials 302,219 155,037 $ 1,651,246 $ 1,206,377

Related Party Investment

Related Party Investment	12 Months Ended
	Dec. 31, 2017
Investments Schedule [Abstract]
Related Party Investment	NOTE 4 – RELATED PARTY INVESTMENT On September 12, 2017, the Company and Hengfai Business Development Pte Ltd. (“HBD”) entered into a Securities Exchange Agreement whereby the Company agreed to issue and sell to HBD 683,000 shares of its common stock, which had a market value on that date of $484,930, in exchange for 21,196,552 ordinary shares and an existing three-year warrant to purchase up to 105,982,759 of ordinary shares at an exercise price of SGD$0.040 (US$0.0298) per share of Singapore eDevelopment Limited (“SED”), a company incorporated in Singapore and publicly-listed on the Singapore Exchange Limited. The SED shares and warrants were owned by HBD. One of the directors of the Company, Mr. Heng Fai Ambrose Chan, is a related party to each of HBD and SED. The cost of the investment was determined to be the fair value of the Company’s common stock issued in the transaction, which was determined to have the most readily determinable fair value. In making this assessment, the Company determined, that the SED shares trade on the Singapore Stock Exchange and had a market value of $900,112 and the warrant had an aggregate intrinsic value of approximately $1,343,000 based on a share price of SGD $0.057 (US$ 0.042) as of December 31, 2017. However, the Company determined that these values did not represent a readily determinable fair value due to a potential lack of liquidity of the SED shares and warrants due to a low average trading volume of the SED shares. As a result, as of December 31, 2017, the investment is carried at cost of approximately $485,000.

Property Plant and Equipment

Property Plant and Equipment	12 Months Ended
	Dec. 31, 2017
Property, Plant and Equipment [Abstract]
Property Plant and Equipment	NOTE 5 - PROPERTY PLANT AND EQUIPMENT Property, plant and equipment consisted of the following at December 31: 2017 2016 Estimated Useful Life Machinery and equipment 5-10 years $ 6,796,617 $ 5,879,958 Building and improvements 39 years 1,923,027 1,923,027 Land 185,000 185,000 Leasehold improvements See (1) 722,984 722,984 Furniture and fixtures 7 years 71,903 68,272 Software and websites 3 years 171,007 412,113 Total cost 9,870,538 9,191,354 Less accumulated depreciation 5,064,898 4,617,513 Property, plant, and equipment, net $ 4,805,640 $ 4,573,841 (1)

Intangible Assets and Goodwill

Intangible Assets and Goodwill	12 Months Ended
	Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	NOTE 6 - INTANGIBLE ASSETS AND GOODWILL During 2017 and 2016, the Company spent approximately $12,000 and $74,000, respectively, on capitalized patent prosecution costs. On November 10, 2016, the Company purchased a portfolio of 122 LED patents and a corresponding license from Intellectual Discovery Co. Ltd. for $3,000,000 with funds it had received from a third party, resulting in a net book value of $0 when purchased. In May, 2016, the Company received proceeds of $495,000 for the sale of certain patents that were included in a pool of acquired patents. The Company evaluates acquired patents as related pools of assets for purposes of amortization and impairment, as well as operational evaluation and use. Accordingly, the proceeds received from the sale of the patents will reduce the cost of the pool of assets until the carrying value of the pool is reduced to zero. Any excess proceeds from future sales will result in a gain. The Company also considers the impact that the sale of a portion of the pool has on expected future recoverability on the pool. No impairment was considered necessary as a result of this evaluation. Intangible assets are comprised of the following: December 31, 2017 December 31, 2016 Useful Life Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Acquired intangibles - customer lists and non-compete agreements 5-10 years 1,997,300 1,810,750 186,550 1,997,300 1,721,357 275,943 Acquired intangibles - patents and patent rights Varied (1) 3,155,000 2,603,942 551,058 3,155,000 2,092,767 1,062,233 Patent application costs Varied (2) 1,148,017 664,873 483,144 1,136,465 578,623 557,842 $ 6,300,317 $ 5,079,565 $ 1,220,752 $ 6,288,765 $ 4,392,747 $ 1,896,018 (1) Acquired patents and patent rights are amortized over their expected useful life which is generally the remaining legal life of the patent. As of December 31, 2017, the weighted average remaining useful life of these assets in service was approximately 1.7 years. (2) Patent application costs are amortized over their expected useful life which is generally the remaining legal life of the patent. As of December 31, 2017, the weighted average remaining useful life of these assets in service was approximately 6.3 years. Amortization expense for the year ended December 31, 2017 amounted to approximately $687,000 ($700,000 –2016). Expected amortization for each of the five succeeding fiscal years is as follows: Year Amount 2018 $ 542,089 2019 $ 277,570 2020 $ 183,606 2021 $ 81,731 2022 $ 80,102 Goodwill The Company performed its annual goodwill impairment test as of December 31, 2017. The Company has goodwill attributed to two of its reporting units which are its Packaging and Plastics reporting units respectively. The Company performed the first step of the goodwill impairment test by comparing the fair value of each of its reporting units with their carrying amounts including goodwill. In performing this step, the Company determined estimates of fair value using a discounted cash flow model for each of these reporting units. The Company determined that it’s Packaging and Plastic reporting units each had to fair values in excess of their carrying value and therefore, did not have an indication of goodwill impairment. There are inherent assumptions and estimates used in developing future cash flows requiring management’s judgment in applying these assumptions and estimates to the analysis of identifiable intangibles and asset impairment including projecting revenues, timing and amount of claim or settlements related to patent infringement cases, royalty rates, interest rates, and the cost of capital. Many of the factors used in assessing fair value are outside the Company’s control and it is reasonably likely that assumptions and estimates will change in future periods. These changes can result in future impairments. The changes in the carrying amount of goodwill for the years ended December 31, 2017 and 2016 are as follows: Packaging Plastics Total Balance as of January 1, 2016 Goodwill $ 1,768,400 $ 684,949 $ 2,453,349 Accumulated impairment losses - - - 1,768,400 684,949 2,453,349 Balance as of December 31, 2016 Goodwill 1,768,400 684,949 2,453,349 Accumulated impairment losses - - - 1,768,400 684,949 2,453,349 Balance as of December 31, 2017 Goodwill 1,768,648 684,949 2,453,597 Accumulated impairment losses - - - $ 1,768,648 $ 684,949 $ 2,453,597

Short-Term and Long-Term Debt

Short-Term and Long-Term Debt	12 Months Ended
	Dec. 31, 2017
Debt Disclosure [Abstract]
Short-Term and Long-Term Debt	NOTE 7 – SHORT TERM AND LONG TERM DEBT Revolving Credit Lines On July 26, 2017, Premier Packaging entered into a Modification and Extension Agreement and accompanying Term Note Non-Revolving Line of Credit Agreement with Citizens Bank pursuant to which Citizens agrees to lend up to $1,200,000 for the purpose of enabling Premier Packaging to purchase equipment from time to time that it may need for use in its business. As of the date of this report, the revolving line had a balance of $0. On December 1, 2017, the Company’s subsidiary Plastic Printing Professionals entered into a Loan Agreement and accompanying Term Note Non-Revolving Line of Credit Agreement with Citizens Bank pursuant to which Citizens agreed to lend up to $800,000 for the purpose of enabling Plastic Printing Professionals to purchase equipment from time to time that it may need for use in its business. Advances may be made under this Equipment Acquisition Line of Credit, from time to time, from December 1, 2017 until December 1, 2018. The aggregate principal balance outstanding under the Equipment Acquisition Line of Credit bears interest at 2% above the LIBOR Advantage Rate (as defined in the Agreement) (3.44% at December 31, 2017) until converted. Effective on conversion, the interest rate payable on the aggregate principal balance outstanding shall be adjusted to a fixed rate equal to 2% above Citizens’ cost of funds as determined by Citizens. Prior to conversion, interest on the outstanding principal is payable in arrears monthly.After conversion, the aggregate principal balance may be repaid in (i) up to 84 installments comprised of principal and interest for new equipment or (ii) up to 60 installments comprised of principal and interest for used equipment. An initial advance was made under the Equipment Acquisition Line of Credit on December 1, 2017, in the amount of $522,000, to fund the purchase of a used 6-color commercial press. Long-Term Debt On May 24, 2013, the Company entered into a promissory note in the principal sum of $850,000 to purchase three printing presses that were previously leased by the Company’s wholly-owned subsidiary, Secuprint Inc., and carries an interest rate of 9% per annum. The note is secured by the assets of Company’s wholly-owned subsidiary, Secuprint Inc. Interest is payable quarterly, in arrears. The Company also issued the lender as additional consideration a five-year warrant to purchase up to 60,000 shares of the Company’s common stock at an exercise price of $3.00 per share. The warrant was valued at approximately $69,000 using the Black-Scholes-Merton option pricing model with a volatility of 60.0%, a risk free rate of return of 0.89% and zero dividend and forfeiture estimates. In conjunction with the issuance of the warrants, the Company recorded a discount on debt of approximately $69,000 that was amortized over the original term of the note. The note was set to mature on May 24, 2014, but its maturity date was extended on May 2, 2014 to May 24, 2015 by the lender. In exchange for the extension, the Company also issued the lender as additional consideration a five-year warrant to purchase up to 40,000 shares of the Company’s common stock at an exercise price of $1.50 per share. The warrant was valued at approximately $29,000 using the Black-Scholes-Merton option pricing model with a volatility of 70.0%, a risk free rate of return of 1.53% and zero dividend and forfeiture estimates. In conjunction with the issuance of the warrants, the Company recorded expense for modification of debt of approximately $29,000. On February 23, 2015, the Company entered into Promissory Note Amendment No. 2 to extend the maturity date to May 31, 2016 and to institute principal payments in the amount of $15,000 per month plus interest through the extended maturity date, and a balloon payment of $610,000 due on the extended maturity date. On April 12, 2016, the Company entered into Promissory Note Amendment No. 3 to extend the maturity date to May 31, 2017 and change the balloon payment to $430,000 due on the extended maturity date. On May 31, 2017, the Company entered into Convertible Promissory Note Amendment No. 4 to extend the maturity date to December 31, 2018 at which point the note is scheduled to be paid in full. In exchange for the extension, the Company also issued the lender as additional consideration 18,000 shares of the Company’s common stock which had a fair value of $17,640. As of December 31, 2017, the balance of the term loan was $325,000 ($505,000 at December 31, 2016). Term Loan Debt On April 28, 2015, Premier Packaging entered into a term note with Citizens for $525,000, repayable over a 60-month period. The loan bears interest at 3.62% and is payable in equal monthly installments of $9,591 until April 28, 2020. Premier Packaging used the proceeds of the term note to acquire a HP Indigo 7800 Digital press. The loan is secured by the printing press. As of December 31, 2017, the loan had a balance of $257,007 ($360,611 at December 31, 2016). Promissory Notes On December 6, 2013, Premier Packaging entered into a Construction to Permanent Loan with Citizens Bank for up to $450,000 that was converted into a promissory note upon the completion and acceptance of building improvements to the Company’s packaging plant in Victor, New York. In May 2014, the Company converted the loan into a $450,000 note payable in monthly installments over a 5 year period of $2,500 plus interest calculated at a variable rate of 1 Month Libor plus 3.15% (4.52% at December 31, 2017), which payments commenced on July 1, 2014. The note matures in July 2019 at which time a balloon payment of the remaining principal balance of $300,000 is due. As of December 31, 2017, the note had a balance of $345,000 ($375,000 at December 31, 2016). The Citizens Bank credit facilities to each of the Company’s subsidiaries, Premier Packaging and Plastic Printing Professionals, contain various covenants including fixed charge coverage ratio, tangible net worth and current ratio covenants. For the year December 31, 2017, both Premier Packaging and Plastic Printing Professionals were in compliance with the covenants. A summary of scheduled principal payments of long-term debt, not including revolving lines of credit and other debt which can be settled with non-monetary assets and net of deferred financing costs, subsequent to December 31, 2017 are as follows: Year Amount 2018 $ 966,506 2019 596,018 2020 209,528 2021 824,226 2022 104,400 Total $ 2,700,678 Other Debt On March 27, 2014, DSSTM received an additional $1,000,000 under the Agreement comprised of a promissory note for $900,000 and fixed and contingent equity interests of $100,000. On September 5, 2014, DSSTM received the remaining $1,500,000 under the Agreement comprised of a promissory note for $1,350,000 and fixed and contingent return interests of $150,000. On May 23, 2016, DSSTM remitted $495,000 in proceeds received from the sale of patent assets (Note 6) to Fortress under the terms of the Agreement. On September 20, 2016, DSSTM remitted $125,250 in proceeds received from a settlement to Fortress as repayment of the note principal balance under the terms of the Agreement. The Agreement defines certain events as Events of Default, one of which is the failure by DSSTM, on or before the second anniversary of the Effective Date, to make payments to the Investors equal to the outstanding Advances. On February 13, 2016, being the second anniversary date of the Effective Date, DSSTM had failed to make these payments and was therefore in default of the Agreement. On December 2, 2016, the parties entered into a First Amendment to Investment Agreement and Certain Other Documents (the “Amendment”). The purpose of the Amendment was to vacate DSSTM’s ongoing non-payment default under the Agreement, and to amend certain provisions of the Agreement. The Agreement was amended to add expenses in the amount of $150,000 to DSSTM’s payment obligation, payable on the Maturity Date. This amount was recorded as debt issuance costs and is being amortized on a straight line basis through the amended maturity date of February 13, 2018. The Amendment added a provision whereby DSSTM is required to deposit $300,000 on or before March 2, 2017 and (ii) a further sum of $300,000 on or before March 2, 2018, into a deposit account (collectively, the “Deposit”). The March 2, 2017 deposit was made in a timely manner. The Deposit funds will be restricted to pay certain expenses, consisting of out-of-pocket expenses incurred in connection with certain existing patent litigation matters and other patent litigation matters which may occur after the Amendment Effective Date (the “Qualified Expenses”). In the Event of Default, the Investors may apply the then remaining Deposit to the then outstanding Obligations, if any. Additionally, per the Amendment, DSSTM agrees to pay to the Investors an amount equal to 25% of any amounts received by DSSTM for any and all types of monetization activities related to certain of its patents covering systems and methods of using low power wireless peripheral devices (collectively, “BlueTooth Patents”), but only until the Investors have received payments under the Agreement totaling the sum of (i) the Capitalized Expenses plus (ii) payments of principal and interest on the Notes totaling the sum of (x) $4,500,000 (consisting of the previously made Advances) plus (y) additional amounts, if any, advanced by the Investors pursuant to the Agreement. In addition to the monetization interest granted the Investors in the BlueTooth Patents, DSSTM also granted the Collateral Agent and the Investors a security interest in certain of DSSTM’s unencumbered semiconductor patents to further collateralize the amounts owed under the Agreement. As of December 31, 2017, DSSTM has made aggregate principal payments of $770,250 on the notes. As of December 31, 2017, $3,702,129 is recorded as a short-term debt under the arrangement, which includes $281,500 of accrued interest, less unamortized debt issuance costs of $29,994. In addition, as of December 31, 2017, $459,000 of fixed and contingent equity interests is recorded in other short-term liabilities. On February 13, 2018, the Maturity Date, DSS Technology Management again defaulted by failing to pay the investors an amount equal to (x) two times the aggregate amount of all advances made by the investors as of such date plus (y) the Capitalized Expenses. The sole recourse available to the investors under the agreement is the establishment of a special purpose entity controlled by the investors which would take ownership of the collateral consisting of the patents covered under the agreement, as amended. Each of the investors and the collateral agent have contractually agreed that they will not, individually or collectively, seek to enforce any monetary judgment with respect to or against any assets of the Company other than the patents and the monetization payments and the remaining deposit.

Other Liabilities

Other Liabilities	12 Months Ended
	Dec. 31, 2017
Other Liabilities Disclosure [Abstract]
Other Liabilities	NOTE 8 – OTHER LIABILITIES On November 14, 2016, the Company entered into a Proceeds Investment Agreement (the “Agreement”) with Brickell Key Investments LP (“BKI”). Pursuant to the Agreement, BKI financed an aggregate of $13,500,000 in a patent purchase and monetization program to be implemented and managed by the Company (the “Financing”). Pursuant to the Agreement. $3,000,000 of the Financing was used to cover the Company’s purchase of a portfolio of U.S. and foreign LED patents and a license from Intellectual Discovery Co., Ltd., a Korean company (collectively, the “LED Patent Portfolio”), resulting in a basis in these assets of $0. A total of $6,000,000 of the Financing was directed by BKI to attorneys to cover anticipated attorneys’ fees and out-of-pocket expenses for legal proceedings that may transpire relating to enforcement of the LED Patent Portfolio. This amount is not included in the Company’s financial statements as the Company has no control over these funds, which are segregated and escrowed in the attorneys’ trust account. In addition, on November 14, 2016, the Company received $4,500,000 of the Financing, which was required to be used by the Company to pay for the defense of Inter Partes Review Inter Partes Review Inter Partes Review Inter Partes Review On July 8, 2013, the Company’s subsidiary, DSS Technology Management, purchased two patents for $500,000 covering certain methods and processes related to Bluetooth devices. In conjunction with the patent purchases, DSS Technology Management entered into a Proceed Right Agreement with certain investors pursuant to which DSS Technology Management initially received $250,000 of a total of $750,000 which it will ultimately receive thereunder, subject to certain payment milestones, in exchange for 40% of the proceeds which it receives, if any, from the use, sale or licensing of the two patents. As of December 31, 2017, the Company had received an aggregate of $650,000 ($650,000 in 2016) from the investors pursuant to the agreement of which approximately $432,000 was in other liabilities in the consolidated balance sheets ($467,000 as December 31, 2016). The Company will reduce the liability as it pays legal and other expenses related to its litigation involving the Bluetooth patents, for which the amount is available to be used for 50% of all such expenses. As described in Note 7, On February 13, 2014, the Company’s subsidiary, DSSTM entered into an Investment Agreement with Fortress pursuant to which DSSTM contracted to receive a series of advances up to $4,500,000. Under the terms of the Agreement, on the Effective Date, DSSTM issued and sold a promissory note in the amount of $1,791,000, fixed return equity interests in the amount of $199,000, and contingent equity interests in the amount of $10,000. On March 27, 2014, DSSTM received an additional $1,000,000 under the Agreement comprised of a promissory note for $900,000 and fixed and contingent equity interests of $100,000. On September 5, 2014, DSSTM received the remaining $1,500,000 under the Agreement comprised of a promissory note for $1,350,000 and fixed and contingent return interests of $150,000. The $495,000 of aggregate fixed and contingent equity interests received are recorded in other liabilities. The Company will reduce the liability upon payment to the Investor from available proceeds from litigation, or if none by the maturity date of February 13, 2018, then such amounts will be reversed from other liabilities and recorded as other income sometime in 2018.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2017
Equity [Abstract]
Stockholders' Equity	NOTE 9 - STOCKHOLDERS’ EQUITY On August 26, 2016, the Company affected a one-for-four reverse stock split of the Company’s common stock. All references in this report to the number of shares of our common stock and to related per-share prices (including references to periods prior to the effective date of the reverse stock split) reflect this reverse stock split. Sales of Equity On September 12, 2017, the Company and Hengfai Business Development Pte Ltd. (“HBD”) entered into a Securities Exchange Agreement whereby the Company agreed to issue and sell to HBD 683,000 shares of its common stock, which had a market value on that date of $484,930, in exchange for 21,196,552 ordinary shares and an existing three-year warrant to purchase up to 105,982,759 of common shares at an exercise price of SGD$0.040 (US$0.0298) per share of Singapore eDevelopment Limited (“SED”), a company incorporated in Singapore and publicly-listed on the Singapore Exchange Limited. The SED shares and warrants were owned by HBD. The cost of the investment was the fair value of the Company’s common stock issued in the transaction which was determined to have the most readily determinable fair value. In conjunction with these transactions, the Company recorded $13,660 in stock listing fees. As of December 31, 2017, the investment is carried at cost of approximately $485,000. On November 1, 2017, the Company issued 500,000 shares of its common stock, and a three-year warrant to purchase up to 125,000 additional shares of the Company’s common stock at an exercise price of $1.00 per share, along with a cash payment of $125,000, to Nix, Patterson & Roach LLP (“NPR”), a law firm, for the purpose of settling all accrued and outstanding billed and unbilled invoices for expenses owed by the Company to NPR of approximately $714,000 in connection with various litigation matters handled by NPR on behalf of the Company. The warrants had an estimated aggregate fair value of approximately $40,000 which was determined by utilizing the Black-Scholes-Merton option pricing model with a volatility of 89.1%, a risk free rate of return of 2.0% and zero dividend and forfeiture estimates. The aggregate estimated fair value of the cash payment and equity instruments issued to NPR was approximately $495,000 which resulted in a reduction of approximately $219,000 of legal expense recorded by the Company, and presented in general and administrative expenses on the Company’s financial statements, in conjunction with the agreement. On December 29, 2016, the Company completed the sale of 300,000 shares of its common stock and a warrant to purchase up to 200,000 shares of the Company’s common stock at an exercise price of $1.00 per share for an aggregate purchase price of $225,000 pursuant to a securities purchase agreement. The warrants had an estimated aggregate fair value of approximately $87,000 which was determined by utilizing the Black-Scholes-Merton option pricing model with a volatility of 86.4%, a risk free rate of return of 1.96% and zero dividend and forfeiture estimates. The Company was assessed $25,000 in listing fees by the NYSE American for equity issuances during 2016. Stock Warrants The Company issued five-year warrants to purchase up to 200,000 shares of the Company’s common stock as part of the December 29, 2016 equity sale at an exercise price of $1.00 per share. The following is a summary with respect to warrants outstanding and exercisable at December 31, 2017 and 2016 and activity during the years then ended: 2017 2016 Weighted Weighted Average Average Exercise Exercise Warrants Price Warrants Price Outstanding at January 1: 2,812,515 $ 11.20 1,862,515 16.40 Granted during the year 391,667 1.00 950,000 1.00 Exercised/lapsed/terminated (559,092 ) 5.11 - - Outstanding at December 31: 2,645,090 $ 10.98 2,812,515 11.20 Exercisable at December 31: 2,645,090 $ 10.98 2,812,515 11.20 Weighted average months remaining 24.3 34.6 Stock Options The following is a summary with respect to options outstanding at December 31, 2017 and 2016 and activity during the years then ended: 2017 2016 Number of Options Weighted Average Exercise Price Weighted Average Life Remaining Number of Options Weighted Average Exercise Price Weighted Average Life Remaining (in years) (in years) Outstanding at January 1: 635,597 9.33 1,106,140 11.56 Granted - - 37,500 1.00 Lapsed/terminated (152,930 ) 9.67 (508,043 ) 13.56 Outstanding at December 31: 482,667 10.72 3.3 635,597 9.33 3.7 Exercisable at December 31: 478,500 9.29 3.3 610,611 10.85 3.7 Expected to vest at December 31: 4,167 1.00 3.3 25,000 1.00 4.3 Aggregate intrinsic value of outstanding options at December 31: $ 10,000 $ - Aggregate intrinsic value of exercisable options at December 31: $ 6,667 $ - Aggregate intrinsic value of options expected to vest at December 31: $ 3,333 $ - There were no options granted in 2017. The weighted-average grant date fair value of options granted during the year ended December 31, 2016 was $0.10. The aggregate grant date fair value of options that vested during 2017 was approximately $417 ($71,000 -2016). There were no options exercised during 2017 or 2016. The fair value of each option award is estimated on the date of grant utilizing the Black-Scholes-Merton Option Pricing Model. The Company estimated the expected volatility of the Company’s common stock at the grant date using the historical volatility of the Company’s common stock over the most recent period equal to the expected stock option term. In March 2016, three of the Company’s senior management voluntarily cancelled an aggregate of 75,000 options to purchase shares of the Company’s common stock with exercise prices of $12.00 per share, of which 41,667 of the options were unvested on the date of cancellation resulting in a reversal of previously recognized stock based compensation expense of approximately $36,000. The following table shows our weighted average assumptions used to compute the share-based compensation expense for stock options and warrants granted during the year ended December 31, 2016. There were no options or warrants granted for compensation during the year ended December 31, 2017. Volatility 85.6 % Expected option term 3.5 years Risk-free interest rate 1.3 % Expected forfeiture rate 0.0 % Expected dividend yield 0.0 % Restricted Stock On January 12, 2017, the Company issued an aggregate of 150,000 shares of restricted stock to members of the Company’s management team of which 100,000 vested on May 17, 2017 and had an aggregated grant date fair value of approximately $126,000. The remaining 50,000 vested if the Company achieved adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of at least $500,000 and a stock trading price of at least $1.00 per share by the close of the fourth quarter of 2017, both of which were achieved. During 2016, the Company issued 6,250 shares of restricted common stock to a consultant providing marketing services to the Company. The restricted shares vested on May 2, 2016 and had an aggregate grant date fair value of approximately $6,250. In addition, during 2016 the Company issued an aggregate of 224,750 shares of restricted stock to members of the Company’s management which will vest on May 17, 2017 and had an aggregated grant date fair value of approximately $124,000. The following is a summary of activity of restricted stock during the years ended at December 31, 2017 and 2016: Shares Weighted - average Grant Date Fair Value Restricted shares outstanding, December 31, 2015 15,000 $ 0.88 Restricted shares granted 231,000 0.56 Restricted shares vested (15,000 ) 0.88 Restricted shares outstanding, December 31, 2016 231,000 $ 0.56 Restricted shares granted 150,000 0.84 Restricted shares vested (331,000 ) 0.64 Restriced shares outstanding, December 31, 2017 50,000 $ 0.64 Stock-Based Compensation

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 10 - INCOME TAXES Following is a summary of the components giving rise to the income tax expense (benefit) for the years ended December 31: The expense (benefit) for income taxes consists of the following: 2017 2016 Currently payable: Federal $ (16,694 ) $ 132,835 State 8,572 (5,617 ) Total currently payable (8,122 ) 127,218 Deferred: Federal (410,402 ) (379,710 ) State (58,001 ) (111,642 ) Total deferred (468,403 ) (491,352 ) Less: increase in valuation allowance 524,381 374,864 Plus: effect of tax change (68,818 ) - Net deferred (12,840 ) (116,488 ) Total income tax expense (benefit) $ (20,962 ) $ 10,730 Individual components of deferred taxes are as follows: 2017 2016 Deferred tax assets: Net operating loss carry forwards $ 10,063,436 $ 15,302,177 Equity issued for services 146,029 280,975 Goodwill and other intangibles 997,676 1,684,346 Investment in pass-through entity 11,575 17,898 Deferred revenue 807,959 1,522,258 Other 523,937 849,325 Gross deferred tax assets 12,550,612 19,656,979 Deferred tax liabilities: Goodwill and other intangibles 169,170 277,231 Depreciation and amortization 62,288 272,406 Gross deferred tax liabilities 231,458 549,637 Less: valuation allowance (12,445,136 ) (19,152,961 ) Net deferred tax liabilities $ (125,982 ) $ (45,619 ) On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act makes broad and complex changes to the U.S. tax code, including, but not limited to, (1) reducing the U.S. federal corporate tax rate from 35 percent to 21 percent; (2) elimination of the corporate alternative minimum tax (AMT) and changing how existing AMT credits can be realized; and (3) changing rules related to usage and limitation of net operating loss carryforwards created in tax years beginning after December 31, 2017, The effect of the rate change attributable to the Tax Act on the Company’s effective tax rate was 11.5% (or $68,818) decrease in the net deferred tax liability. The Tax Act repeals the corporate alternative minimum tax (AMT) and permits existing minimum tax credits carryovers to offset the regular tax liability for any tax year. Further, the credit is refundable for any tax year beginning after December 31, 2017 and before December 31, 2020 in an amount equal to 50 percent of the excess of the minimum tax credit over regular liability. Any remaining credit will be fully refundable for the year ended December 31, 2021. As of December 31, 2017, the Company had $93,201 of minimum tax credit recorded as a deferred tax asset, which was reclassified as to a current and non-current receivable of 46,600 and 46,601 respectively. The Company has approximately $47.2 million in federal net operating loss carryforwards (“NOLs”) available to reduce future taxable income, which will expire at various dates from 2022 through 2036. Due to the uncertainty as to the Company’s ability to generate sufficient taxable income in the future and utilize the NOLs before they expire and any other deferred tax assets, the Company has recorded a valuation allowance accordingly. The Company’s NOLs are subject to annual limitations as a result of a change in its equity ownership as defined under the Internal Revenue Code Section 382. These limitations, as applicable, could further limit the use of the NOLs. The valuation allowance for deferred tax assets decreased by approximately $6.9 million in the year ended December 31, 2017. The decreases in the valuation allowance was primarily due to the revaluation of the deferred taxes due to the enactment of the Tax Cuts and Jobs Act. The Company has adopted the provisions of ASU 2016-09 as of the beginning of the year which requires recognition through opening retained earnings of any pre-adoption date NOL carryforwards from nonqualified stock options and other employee share-based payments (e.g., restricted shares and share appreciation rights), as well as recognition of all income tax effects from share-based payments arising on or after January 1, 2017 (our adoption date) in income tax expense. In light of the Company’s valuation allowance on its deferred tax assets there was no adjustment required to its retained earnings nor was there any windfall tax benefit to recognize in the Company’s income tax provision. The differences between the United States statutory federal income tax rate and the effective income tax rate in the accompanying consolidated statements of operations are as follows: 2017 2016 Statutory United States federal rate 34.0 % 34.0 % State income taxes net of federal benefit 5.5 5.0 Permanent differences 0.8 (3.9 ) Other - (0.4 ) Tax rate change 11.5 - Change in valuation reserves (48.2 ) (35.8 ) Effective tax rate 3.6 % (1.1 )% The Company recognizes interest accrued and penalties related to unrecognized tax benefits in tax expense. During the years ended December 31, 2017 and 2016, the Company recognized no interest and penalties. The Company files income tax returns in the U.S. federal jurisdiction and various states. The tax years 2014-2017 generally remain open to examination by major taxing jurisdictions to which the Company is subject.

Defined Contribution Pension Pl

Defined Contribution Pension Plan	12 Months Ended
	Dec. 31, 2017
Retirement Benefits [Abstract]
Defined Contribution Pension Plan	NOTE 11 - DEFINED CONTRIBUTION PENSION PLAN The Company maintains a qualified employee savings plans (the “401(k) Plan”) that qualifies as a deferred salary arrangement under Section 401(k) of the Internal Revenue Code and which covers all eligible employees. Employees generally become eligible to participate in the 401(k) Plan two months following the employee’s hire date. Employees may contribute a percentage of their earnings, subject to the limitations of the Internal Revenue Code. Until December 31, 2017, the Company matched up to 50% of the employee’s contribution up to a maximum match of 3%. The total matching contributions for 2017 were approximately $103,000 ($101,000 -2016). Commencing on January 1, 2018, the Company will match 100% of the first 1% of employee contributions, then 50% of additional contributions up to an aggregate maximum match of 3.5%.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 12 – COMMITMENTS AND CONTINGENCIES Facilities - Equipment Leases The following table summarizes the Company’s lease commitments. Operating Leases Equipment Facilities Total Payments made in 2017 $ 44,131 $ 259,385 $ 303,516 Future minimum lease commitments: 2018 $ 43,258 $ 258,530 $ 301,788 2019 14,419 68,820 83,239 2020 - 68,820 68,820 Total 57,677 396,170 453,847 Total future minimum lease commitments $ 57,677 $ 396,170 $ 453,847 Employment Agreements Legal Proceedings On February 16, 2015, DSS Technology Management filed suit in the United States District Court, Eastern District of Texas, against defendants Intel Corporation, Dell, Inc., GameStop Corp., Conn’s Inc., Conn Appliances, Inc., NEC Corporation of America, Wal-Mart Stores, Inc., Wal-Mart Stores Texas, LLC, and AT&T, Inc. The complaint alleges patent infringement and seeks judgment for infringement of two of DSSTM’s patents, injunctive relief and money damages. On December 9, 2015, Intel filed IPR petitions with PTAB for review of the patents at issue in the case. Intel’s IPRs were instituted by PTAB on June 8, 2016. On June 1, 2017, the PTAB ruled in favor of Intel for all the challenged claims. On July 28, 2017, DSS Technology Management filed a notice of appeal of the PTAB’s decision relating to U.S. Patent 6,784,552 with the Federal Circuit. The Intel litigation has been stayed by the District Court pending final determination of the IPR proceedings. On July 16, 2015, DSS Technology Management filed three separate lawsuits in the United States District Court for the Eastern District of Texas alleging infringement of certain of its semiconductor patents. The defendants are SK Hynix et al., Samsung Electronics et al., and Qualcomm Incorporated. Each respective complaint alleges patent infringement and seeks judgment for infringement, injunctive relief and money damages. On November 12, 2015, SK Hynix filed an IPR petition with PTAB for review of the patent at issue in their case. SK Hynix’s IPR was instituted by the PTAB on May 11, 2016. On August 16, 2016, DSS Technology Management and SK Hynix entered into a confidential settlement agreement ending the litigation between them. The pending SK Hynix IPR was then terminated by mutual agreement of the parties on August 31, 2016. On March 18, 2016, Samsung also filed an IPR petition, which was instituted by the PTAB. On September 20, 2017, PTAB ruled in favor of Samsung for all the challenged claims relating to U.S. Patent 6,784,552. DSS Technology Management then appealed this PTAB ruling to the Federal Circuit on November 17, 2017. The Federal Circuit joined this appeal with the Intel appeal effective on December 7, 2017. The appeal is still pending as of the date of this Report. Qualcomm filed its IPR proceeding on July 1, 2016, which was then later joined with Intel’s IPRs in August 2016 by PTAB. On June 1, 2017, the PTAB ruled in favor of Intel/Qualcomm for all the challenged claims. On July 28, 2017, DSS Technology Management filed a notice of appeal of the PTAB’s decision relating to U.S. Patent 6,784,552 with the Federal Circuit. As indicated above, this joint appeal is still pending as of the date of this Report. On April 13, 2017, Document Security Systems, Inc. (“DSS”) filed a patent infringement lawsuit against Seoul Semiconductor Co., Ltd. and Seoul Semiconductor, Inc. (collectively, “Seoul Semiconductor”) in the United States District Court for the Eastern District of Texas, alleging infringement of certain of DSS’s Light-Emitting Diode (“LED”) patents. DSS is seeking a judgement for infringement of the patents along with other relief including, but not limited to, money damages, costs and disbursements. On June 7, 2017, DSS refiled its patent infringement complaint against Seoul Semiconductor in the United States District Court for the Central District of California, Southern Division. The case is currently pending. On December 3, 2017, Seoul Semiconductor filed an IPR challenging the validity of certain claims of U.S. Patent No. 6,949,771. On December 21, 2017, Seoul Semiconductor filed an IPR challenging the validity of certain claims of U.S. Patent No. 7,256,486. On January 25, 2018, Seoul Semiconductor filed an IPR challenging the validity of certain claims of U.S. Patent No. 7,524,087. These challenged patents the patents that are the subject matter of the infringement lawsuit, and are still pending as of the date of this Report. On April 13, 2017, DSS filed a patent infringement lawsuit against Everlight Electronics Co., Ltd. and Everlight Americas, Inc. (collectively, “Everlight”) in the United States District Court for the Eastern District of Texas, Marshall Division, alleging infringement of certain of DSS’s LED patents. DSS is seeking a judgement for infringement of the patents along with other relief including, but not limited to, money damages, costs and disbursements. On June 8, 2017, DSS refiled its patent infringement complaint against Everlight in the United States District Court for the Central District of California. The case is currently pending as of the date of this Report. On April 13, 2017, DSS filed a patent infringement lawsuit against Cree, Inc. (“Cree”) in the United States District Court for the Eastern District of Texas, Marshall Division, alleging infringement of certain of DSS’s LED patents. DSS is seeking a judgement for infringement of the patents along with other relief including, but not limited to, money damages, costs and disbursements. On June 8, 2017, DSS refiled its patent infringement complaint against Cree in the United States District Court for the Central District of California, and thereafter filed a first amended complaint for patent infringement against Cree in that same court on July 14, 2017. The case is currently pending as of the date of this Report. On July 13, 2017, DSS filed a patent infringement lawsuit against Osram GMBH, Osram OPTO Semiconductors GMBH & Co., and Osram Sylvania Inc. (collectively, “Osram”) in the United States District Court for the Central District of California, alleging infringement of certain of DSS’s LED patents. DSS is seeking a judgment for infringement of the patents along with other relief including, but not limited to, money damages, costs and disbursements. On February 21, 2018, DSS and Osram executed a confidential settlement agreement ending the litigation between them. On August 15, 2017, DSS filed a patent infringement lawsuit against Lite-On, Inc., and Lite-On Technology Corporation in the United States District Court for the Central District of California, alleging infringement of certain of DSS’s LED patents. DSS is seeking a judgement for infringement of the patents along with other relief including, but not limited to, money damages, costs and disbursements. The case is currently pending as of the date of this Report. On December 7, 2017, DSS filed a patent infringement lawsuit against Nichia Corporation and Nichia America Corporation in the United States District Court for the Central District of California, alleging infringement of certain of DSS’s LED patents. DSS is seeking a judgement for infringement of the patents along with other relief including, but not limited to, money damages, costs and disbursements. The case is currently pending as of the date of this Report. In addition to the foregoing, we may become subject to other legal proceedings that arise in the ordinary course of business and have not been finally adjudicated. Adverse decisions in any of the foregoing may have a material adverse effect on our results of operations, cash flows or our financial condition. The Company accrues for potential litigation losses when a loss is probable and estimable. Contingent Litigation Payments Contingent Payments

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	12 Months Ended
	Dec. 31, 2017
Supplemental Cash Flow Information [Abstract]
Supplemental Cash Flow Information	NOTE 13 - SUPPLEMENTAL CASH FLOW INFORMATION Supplemental cash flow information for the years ended December 31: 2017 2016 Cash paid for interest $ 141,000 $ 210,000 Non-cash investing and financing activities: Gain from change in fair value of interest rate swap derivative 22,000 18,000 Capitalized debt modification costs that increase debt balance $ - $ 150,000 Account payable settled with issuance of equity instruments $ 370,000 $ - Common Stock issued for investment $ 485,000 $ -

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2017
Segment Reporting [Abstract]
Segment Information	NOTE 14 - SEGMENT INFORMATION The Company’s businesses are organized, managed and internally reported as four operating segments. Two of these operating segments, Packaging and Printing and Plastics, are engaged in the printing and production of paper, cardboard and plastic documents with a wide range of features, including the Company’s patented technologies and trade secrets designed for the protection of documents against unauthorized duplication and altering. The two other operating segments, DSS Digital Group, and DSS Technology Management, Inc., are engaged in various aspects of developing, acquiring, selling and licensing technology assets and are grouped into one reportable segment called Technology. Approximate information concerning the Company’s operations by reportable segment for the years ended December 31, 2017 and 2016 is as follows. The Company relies on intersegment cooperation and management does not represent that these segments, if operated independently, would report the results contained herein: Year Ended December 31, 2017 Packaging and Printing Plastics Technology Corporate Total Revenue $ 12,556,000 4,470,000 1,636,000 - $ 18,662,000 Depreciation and amortization 663,000 134,000 614,000 3,000 1,414,000 Interest expense 107,000 - 62,000 54,000 223,000 Amortized Debt Discount 1,000 - 131,000 22,000 154,000 Stock based compensation - - 40,000 175,000 215,000 Income tax benefit - - - (21,000 ) (21,000 ) Net Income (loss) to common shareholders 1,453,000 385,000 (1,219,000 ) (1,197,000 ) (578,000 ) Capital Expenditures 439,000 520,000 - - 959,000 Identifiable assets 9,331,000 2,933,000 1,725,000 3,442,000 17,431,000 Year Ended December 31, 2016 Packaging and Printing Plastics Technology Corporate Total Revenue $ 12,934,000 4,344,000 1,900,000 - $ 19,178,000 Depreciation and amortization 617,000 122,000 649,000 4,000 1,392,000 Interest Expense 121,000 - 41,000 86,000 248,000 Amortized Debt Discount 2,000 - 29,000 - 31,000 Stock based compensation 17,000 10,000 26,000 276,000 329,000 Income tax benefit - - - 11,000 11,000 Net Income (loss) to common shareholders 1,533,000 447,000 (1,271,000 ) (1,659,000 ) (950,000 ) Capital Expenditures 251,000 18,000 3,117,000 - 3,386,000 Identifiable assets 9,484,000 2,335,000 1,942,000 4,705,000 18,466,000 International revenue, which consists of sales to customers with operations in Canada, Western Europe, Latin America, Africa, the Middle East and Asia comprised 3.2% of total revenue for 2017 (2%- 2016). Revenue is allocated to individual countries by customer based on where the product is shipped. The Company had no long-lived assets in any country other than the United States for any period presented.

Summary of Significant Accoun21

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation
Use of Estimates	Use of Estimates
Reclassifications	Reclassifications
Restricted Cash	Restricted Cash
Accounts Receivable	Accounts Receivable
Inventory	Inventory
Property, Plant and Equipment	Property, Plant and Equipment
Investment	Investment
Goodwill	Goodwill -
Other Intangible Assets and Patent Application Costs	Other Intangible Assets and Patent Application Costs
Impairment of Long Lived Assets	Impairment of Long Lived Assets
Fair Value of Financial Instruments	Fair Value of Financial Instruments ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The carrying amounts reported in the balance sheet of cash, accounts receivable, prepaids, accounts payable and accrued expenses approximate fair value because of the immediate or short-term maturity of these financial instruments. The fair value of revolving credit lines, notes payable and long-term debt approximates their carrying value as the stated or discounted rates of the debt reflect recent market conditions. Derivative instruments, as discussed below, are recorded as assets and liabilities at estimated fair value based on available market information. The fair value of investments carried at cost is estimated to exceed carrying value; however the fair value is not considered readily determinable based on the lack of liquidity for the shares owned.
Derivative Instruments	Derivative Instruments . As of December 31, 2017 the Company has an interest rate swap agreement for its debt with RBS Citizens, N.A. (“Citizens Bank”) (see Note 7) which changes a variable rate into a fixed rate on a term loan as follows: Notional Amount Variable Rate Fixed Cost Maturity Date $ 915,107 4.512 % 5.87 % August 30, 2021
Share-based Payments	Share-Based Payments
Revenue Recognition	Revenue Recognition For technology sales and services, revenue is recognized in accordance with FASB ASC 985-605. Accordingly, revenue is recognized when all of the following conditions are satisfied: (1) there is persuasive evidence of an arrangement; (2) the service or product has been provided to the customer; (3) the amount of fees to be paid by the customer is fixed or determinable; and (4) the collection of our fees is reasonably assured. We recognize cloud computing revenue, including data backup, recovery and security services, on a monthly basis, beginning on the date the customer commences use of our services. Professional services are recognized in the period services are provided. For printing technology licenses, revenue is recognized once all the following criteria for revenue recognition have been met: (1) persuasive evidence of an agreement exists; (2) the right and ability to use the product or technology has been rendered; (3) the fee is fixed and determinable and not subject to refund or adjustment; and (4) collection of the amounts due is reasonably assured. For other technology licenses, revenue arrangements generally provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies owned or controlled the Company, (ii) a covenant-not-to-sue, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional payment. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on the Company’s part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectability is reasonably assured, or upon receipt of the minimum upfront fee for term agreement renewals, and when all other revenue recognition criteria have been met. Certain of the Company’s revenue arrangements provide for future royalties or additional required payments based on future licensee activities. Additional royalties are recognized in revenue upon resolution of the related contingency provided that all revenue recognition criteria, as described above, have been met. Amounts of additional royalties due under these license agreements, if any, cannot be reasonably estimated by management.
Costs of Revenue	Costs of revenue -
Contingent Legal Expenses	Contingent Legal Expenses -
Advertising Costs	Advertising Costs .
Research and Development	Research and Development
Income Taxes	Income Taxes
Earnings Per Common Share	Earnings Per Common Share As of December 31, 2017 and 2016, there were 3,177,759 and 3,672,878, respectively, of common stock share equivalents potentially issuable under convertible debt agreements, employment agreements, options, warrants, and restricted stock agreements that could potentially dilute basic earnings per share in the future. Common stock equivalents were excluded from the calculation of diluted earnings per share for 2017 and 2016 in which the Company had a net loss, since their inclusion would have been anti-dilutive.
Comprehensive Loss	Comprehensive Loss
Concentration of Credit Risk	Concentration of Credit Risk During 2017, two customers accounted for 46% of our consolidated revenue. As of December 31, 2017, these two customers accounted for 38% of our trade accounts receivable balance. During 2016, these two customers accounted for 38% of our consolidated revenue. As of December 31, 2016, these two customers accounted for 31% of our trade accounts receivable balance.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In January 2016, the FASB issued ASU 2016-01, “Recognition and Measurement of Financial Assets and Financial Liabilities”, which requires that most equity investments be measured at fair value, with subsequent changes in fair value recognized in net income. Entities will no longer be able to use the cost method of accounting for equity securities. However, for equity investments without readily determinable fair values, entities may elect a measurement alternative that will allow those investments to be recorded at cost, less impairment, and adjusted for subsequent observable price changes. The pronouncement also impacts financial liabilities under the fair value option and the presentation and disclosure requirements for financial instruments. This pronouncement is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017, and early adoption is not permitted. The Company is currently assessing the impact that adopting this new accounting standard will have on our Consolidated Financial Statements. In February 2016, the FASB issued ASU 2016-02, “Leases”, which requires that lease arrangements longer than 12 months result in an entity recognizing an asset and liability. ASU 2016-02 is effective for interim and annual periods beginning after December 15, 2018, and early adoption is permitted. The Company has not yet evaluated nor has it determined the effect of the standard will have on its consolidated financial statements and related disclosures. In August 2016, the FASB issued ASU 2016-15, “Classification of Certain Cash Receipts and Cash Payments”, which clarifies the treatment of several types of cash receipts and payments for which there was diversity in practice. This update is effective for annual periods beginning after December 15, 2017, and interim periods within those fiscal years, with early adoption permitted, including adoption in an interim period. We anticipate that the adoption of this guidance will not have a material impact on our consolidated financial statements. In November 2016, the FASB issued ASU 2016-18, “Statement of Cash Flows”, regarding the presentation of restricted cash on the statement of cash flows. The standards update requires that the reconciliation of the beginning and end of period cash amounts shown in the statement of cash flows include restricted cash. When restricted cash is presented separately from cash and cash equivalents on the balance sheet, a reconciliation is required between the amounts presented on the statement of cash flows and the balance sheet. Also, the new guidance requires the disclosure of information about the nature of the restrictions. The standards update is effective retrospectively for fiscal years and interim periods beginning after December 15, 2017, with early adoption permitted. In January 2017, the FASB issued ASU 2017-04, “Intangibles – Goodwill and Other (Topic 350) – Simplifying the Test for Goodwill Impairment”, which eliminates the two-step process that required identification of potential impairment and a separate measure of the actual impairment. The annual assessment of goodwill impairment will be determined by using the difference between the carrying amount and the fair value of the reporting unit. The standards update are effective for goodwill impairment tests in fiscal years beginning after December 15, 2019. The Company is currently assessing the impact that adopting this new accounting standard will have on our Consolidated Financial Statements. In May 2017, the FASB issued ASU 2017-09, “Compensation – Stock Compensation (Topic 718) – Scope of Modification Accounting”, which provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. ASU 2017-09 is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, and early adoption is permitted, including in an interim period. ASU 2017-09 is to be applied on a prospective basis to an award modified on or after the adoption date. We do not intend to early adopt ASU 2017-09 and do not expect the adoption of this new accounting standard will have a material impact on our Consolidated Financial Statements. In February 2018, the FASB issued ASU 2018-03, “Technical Corrections and Improvements to Financial Instruments (Subtopic 825-10) – Recognition and Measurement of Financial Assets and Financial Liabilities”. This update was issued to clarify certain narrow aspects of guidance concerning the recognition of financial assets and liabilities established in ASU No. 2016-01, “ ”.
Newly Adopted Accounting Pronouncements	Newly Adopted Accounting Pronouncements In March 2016, the FASB issued ASU 2016-09, “Compensation — Stock Compensation: Improvements to Employee Share-Based Payment Accounting.” The standard is intended to simplify several areas of accounting for share-based compensation arrangements, including the income tax impact, classification on the statement of cash flows and forfeitures. ASU 2016-09 was effective for the Company as of January 1, 2017. Adoption of this new accounting standard resulted in the recognition of an increase in the Company’s gross deferred tax asset of approximately $350,000 and an offsetting increase in the valuation allowance. There was no impact to the Company’s retained earnings or other material impact to the financial statements as a result of adopting this new accounting standard.

Summary of Significant Accoun22

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Schedule of Derivative Instruments	As of December 31, 2017 the Company has an interest rate swap agreement for its debt with RBS Citizens, N.A. (“Citizens Bank”) (see Note 7) which changes a variable rate into a fixed rate on a term loan as follows: Notional Amount Variable Rate Fixed Cost Maturity Date $ 915,107 4.512 % 5.87 % August 30, 2021

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Dec. 31, 2017
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventory consisted of the following at December 31: 2017 2016 Finished Goods $ 965,757 $ 736,987 Work in process 383,270 314,353 Raw Materials 302,219 155,037 $ 1,651,246 $ 1,206,377

Property Plant and Equipment (T

Property Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2017
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property, plant and equipment consisted of the following at December 31: 2017 2016 Estimated Useful Life Machinery and equipment 5-10 years $ 6,796,617 $ 5,879,958 Building and improvements 39 years 1,923,027 1,923,027 Land 185,000 185,000 Leasehold improvements See (1) 722,984 722,984 Furniture and fixtures 7 years 71,903 68,272 Software and websites 3 years 171,007 412,113 Total cost 9,870,538 9,191,354 Less accumulated depreciation 5,064,898 4,617,513 Property, plant, and equipment, net $ 4,805,640 $ 4,573,841 (1)

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	12 Months Ended
	Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangible assets are comprised of the following: December 31, 2017 December 31, 2016 Useful Life Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Acquired intangibles - customer lists and non-compete agreements 5-10 years 1,997,300 1,810,750 186,550 1,997,300 1,721,357 275,943 Acquired intangibles - patents and patent rights Varied (1) 3,155,000 2,603,942 551,058 3,155,000 2,092,767 1,062,233 Patent application costs Varied (2) 1,148,017 664,873 483,144 1,136,465 578,623 557,842 $ 6,300,317 $ 5,079,565 $ 1,220,752 $ 6,288,765 $ 4,392,747 $ 1,896,018 (1) Acquired patents and patent rights are amortized over their expected useful life which is generally the remaining legal life of the patent. As of December 31, 2017, the weighted average remaining useful life of these assets in service was approximately 1.7 years. (2) Patent application costs are amortized over their expected useful life which is generally the remaining legal life of the patent. As of December 31, 2017, the weighted average remaining useful life of these assets in service was approximately 6.3 years.
Schedule of Estimated Future Amortization of Intangible Assets	Expected amortization for each of the five succeeding fiscal years is as follows: Year Amount 2018 $ 542,089 2019 $ 277,570 2020 $ 183,606 2021 $ 81,731 2022 $ 80,102
Schedule of Changes On Carrying Amount of Goodwill	The changes in the carrying amount of goodwill for the years ended December 31, 2017 and 2016 are as follows: Packaging Plastics Total Balance as of January 1, 2016 Goodwill $ 1,768,400 $ 684,949 $ 2,453,349 Accumulated impairment losses - - - 1,768,400 684,949 2,453,349 Balance as of December 31, 2016 Goodwill 1,768,400 684,949 2,453,349 Accumulated impairment losses - - - 1,768,400 684,949 2,453,349 Balance as of December 31, 2017 Goodwill 1,768,648 684,949 2,453,597 Accumulated impairment losses - - - $ 1,768,648 $ 684,949 $ 2,453,597

Short Term and Long Term Debt (

Short Term and Long Term Debt (Tables)	12 Months Ended
	Dec. 31, 2017
Debt Disclosure [Abstract]
Schedule of Notes Payable and Long-Term Debt	A summary of scheduled principal payments of long-term debt, not including revolving lines of credit and other debt which can be settled with non-monetary assets and net of deferred financing costs, subsequent to December 31, 2017 are as follows: Year Amount 2018 $ 966,506 2019 596,018 2020 209,528 2021 824,226 2022 104,400 Total $ 2,700,678

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2017
Equity [Abstract]
Schedule of Warrant Activity	The following is a summary with respect to warrants outstanding and exercisable at December 31, 2017 and 2016 and activity during the years then ended: 2017 2016 Weighted Weighted Average Average Exercise Exercise Warrants Price Warrants Price Outstanding at January 1: 2,812,515 $ 11.20 1,862,515 16.40 Granted during the year 391,667 1.00 950,000 1.00 Exercised/lapsed/terminated (559,092 ) 5.11 - - Outstanding at December 31: 2,645,090 $ 10.98 2,812,515 11.20 Exercisable at December 31: 2,645,090 $ 10.98 2,812,515 11.20 Weighted average months remaining 24.3 34.6
Summary of Stock Option Activity Under Stock Option and Incentive Plans	The following is a summary with respect to options outstanding at December 31, 2017 and 2016 and activity during the years then ended: 2017 2016 Number of Options Weighted Average Exercise Price Weighted Average Life Remaining Number of Options Weighted Average Exercise Price Weighted Average Life Remaining (in years) (in years) Outstanding at January 1: 635,597 9.33 1,106,140 11.56 Granted - - 37,500 1.00 Lapsed/terminated (152,930 ) 9.67 (508,043 ) 13.56 Outstanding at December 31: 482,667 10.72 3.3 635,597 9.33 3.7 Exercisable at December 31: 478,500 9.29 3.3 610,611 10.85 3.7 Expected to vest at December 31: 4,167 1.00 3.3 25,000 1.00 4.3 Aggregate intrinsic value of outstanding options at December 31: $ 10,000 $ - Aggregate intrinsic value of exercisable options at December 31: $ 6,667 $ - Aggregate intrinsic value of options expected to vest at December 31: $ 3,333 $ -
Schedule of Assumptions Used to Compute the Share-based Compensation Expense for Stock Options and Warrants	There were no options or warrants granted for compensation during the year ended December 31, 2017. Volatility 85.6 % Expected option term 3.5 years Risk-free interest rate 1.3 % Expected forfeiture rate 0.0 % Expected dividend yield 0.0 %
Summary of Restricted Stock	The following is a summary of activity of restricted stock during the years ended at December 31, 2017 and 2016: Shares Weighted - average Grant Date Fair Value Restricted shares outstanding, December 31, 2015 15,000 $ 0.88 Restricted shares granted 231,000 0.56 Restricted shares vested (15,000 ) 0.88 Restricted shares outstanding, December 31, 2016 231,000 $ 0.56 Restricted shares granted 150,000 0.84 Restricted shares vested (331,000 ) 0.64 Restriced shares outstanding, December 31, 2017 50,000 $ 0.64

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Schedule of Income Tax Provision	Following is a summary of the components giving rise to the income tax expense (benefit) for the years ended December 31: The expense (benefit) for income taxes consists of the following: 2017 2016 Currently payable: Federal $ (16,694 ) $ 132,835 State 8,572 (5,617 ) Total currently payable (8,122 ) 127,218 Deferred: Federal (410,402 ) (379,710 ) State (58,001 ) (111,642 ) Total deferred (468,403 ) (491,352 ) Less: increase in valuation allowance 524,381 374,864 Plus: effect of tax change (68,818 ) - Net deferred (12,840 ) (116,488 ) Total income tax expense (benefit) $ (20,962 ) $ 10,730
Schedule of Deferred Tax Assets and Liabilities	Individual components of deferred taxes are as follows: 2017 2016 Deferred tax assets: Net operating loss carry forwards $ 10,063,436 $ 15,302,177 Equity issued for services 146,029 280,975 Goodwill and other intangibles 997,676 1,684,346 Investment in pass-through entity 11,575 17,898 Deferred revenue 807,959 1,522,258 Other 523,937 849,325 Gross deferred tax assets 12,550,612 19,656,979 Deferred tax liabilities: Goodwill and other intangibles 169,170 277,231 Depreciation and amortization 62,288 272,406 Gross deferred tax liabilities 231,458 549,637 Less: valuation allowance (12,445,136 ) (19,152,961 ) Net deferred tax liabilities $ (125,982 ) $ (45,619 )
Schedule of Effective Income Tax Rate Reconciliation	The differences between the United States statutory federal income tax rate and the effective income tax rate in the accompanying consolidated statements of operations are as follows: 2017 2016 Statutory United States federal rate 34.0 % 34.0 % State income taxes net of federal benefit 5.5 5.0 Permanent differences 0.8 (3.9 ) Other - (0.4 ) Tax rate change 11.5 - Change in valuation reserves (48.2 ) (35.8 ) Effective tax rate 3.6 % (1.1 )%

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Payments Under Operating Leases	The following table summarizes the Company’s lease commitments. Operating Leases Equipment Facilities Total Payments made in 2017 $ 44,131 $ 259,385 $ 303,516 Future minimum lease commitments: 2018 $ 43,258 $ 258,530 $ 301,788 2019 14,419 68,820 83,239 2020 - 68,820 68,820 Total 57,677 396,170 453,847 Total future minimum lease commitments $ 57,677 $ 396,170 $ 453,847

Supplemental Cash Flow Inform30

Supplemental Cash Flow Information (Tables)	12 Months Ended
	Dec. 31, 2017
Supplemental Cash Flow Information [Abstract]
Schedule of Supplemental Cash Flow Information	Supplemental cash flow information for the years ended December 31: 2017 2016 Cash paid for interest $ 141,000 $ 210,000 Non-cash investing and financing activities: Gain from change in fair value of interest rate swap derivative 22,000 18,000 Capitalized debt modification costs that increase debt balance $ - $ 150,000 Account payable settled with issuance of equity instruments $ 370,000 $ - Common Stock issued for investment $ 485,000 $ -

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2017
Segment Reporting [Abstract]
Schedule of Operations by Reportable Segment	The Company relies on intersegment cooperation and management does not represent that these segments, if operated independently, would report the results contained herein: Year Ended December 31, 2017 Packaging and Printing Plastics Technology Corporate Total Revenue $ 12,556,000 4,470,000 1,636,000 - $ 18,662,000 Depreciation and amortization 663,000 134,000 614,000 3,000 1,414,000 Interest expense 107,000 - 62,000 54,000 223,000 Amortized Debt Discount 1,000 - 131,000 22,000 154,000 Stock based compensation - - 40,000 175,000 215,000 Income tax benefit - - - (21,000 ) (21,000 ) Net Income (loss) to common shareholders 1,453,000 385,000 (1,219,000 ) (1,197,000 ) (578,000 ) Capital Expenditures 439,000 520,000 - - 959,000 Identifiable assets 9,331,000 2,933,000 1,725,000 3,442,000 17,431,000 Year Ended December 31, 2016 Packaging and Printing Plastics Technology Corporate Total Revenue $ 12,934,000 4,344,000 1,900,000 - $ 19,178,000 Depreciation and amortization 617,000 122,000 649,000 4,000 1,392,000 Interest Expense 121,000 - 41,000 86,000 248,000 Amortized Debt Discount 2,000 - 29,000 - 31,000 Stock based compensation 17,000 10,000 26,000 276,000 329,000 Income tax benefit - - - 11,000 11,000 Net Income (loss) to common shareholders 1,533,000 447,000 (1,271,000 ) (1,659,000 ) (950,000 ) Capital Expenditures 251,000 18,000 3,117,000 - 3,386,000 Identifiable assets 9,484,000 2,335,000 1,942,000 4,705,000 18,466,000

Summary of Significant Accoun32

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Significant Accounting Policies [Line Items]
Restricted cash	$ 256,005	$ 177,609
Accounts receivable, allowance	50,000	50,000
Depreciation expense	727,000	635,000
Accumulated other comprehensive loss	23,069	45,343
Advertising costs	23,000	27,000
Research and development	$ 106,000	$ 435,000
Antidilutive securities	3,177,759	3,672,878
Deferred tax assets, gross	$ 350,000
Two Customer [Member] | Sales Revenue, Goods, Net [Member]
Significant Accounting Policies [Line Items]
Concentration of credit risk, percentage	46.00%	38.00%
Two Customer [Member] | Accounts Receivable [Member]
Significant Accounting Policies [Line Items]
Concentration of credit risk, percentage	38.00%	31.00%

Summary of Significant Accoun33

Summary of Significant Accounting Policies - Schedule of Derivative Instruments (Details)	12 Months Ended
	Dec. 31, 2017USD ($)
Accounting Policies [Abstract]
Notional Amount	$ 915,107
Variable Rate	4.512%
Fixed Cost	5.87%
Maturity Date	Aug. 30, 2021

Inventory - Schedule of Invento

Inventory - Schedule of Inventory (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Inventory Disclosure [Abstract]
Finished Goods	$ 965,757	$ 736,987
Work in process	383,270	314,353
Raw Materials	302,219	155,037
Inventory	$ 1,651,246	$ 1,206,377

Related Party Investment (Detai

Related Party Investment (Details Narrative) - USD ($)	Sep. 12, 2017	Dec. 31, 2017	Dec. 29, 2016
Warrant exercise price per share			$ 1
Investment costs		$ 485,000
Maximum [Member]
Warrant to purchase of common shares			200,000
Hengfai Business Development Pte Ltd. [Member] | Securities Exchange Agreement [Member]
Sale of common stock shares issued	683,000
Sale of common stock value issued	$ 484,930	900,112
Exchange for ordinary shares	21,196,552
Warrant term	3 years
Warrants aggregate intrinsic value		$ 1,343,000
Singapore eDevelopment Limited [Member] | Securities Exchange Agreement [Member]
Warrant term	3 years
Warrant exercise price per share	$ 0.0298	$ 0.042
Investment costs		$ 485,000
Singapore eDevelopment Limited [Member] | Securities Exchange Agreement [Member] | Singapore, Dollars [Member]
Warrant exercise price per share	$ 0.040	$ 0.057
Singapore eDevelopment Limited [Member] | Securities Exchange Agreement [Member] | Maximum [Member]
Warrant to purchase of common shares	105,982,759

Property Plant and Equipment -

Property Plant and Equipment - Schedule of Property, Plant and Equipment (Details) - USD ($)		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016
Property, Plant and Equipment [Line Items]
Total cost		$ 9,870,538	$ 9,191,354
Less accumulated depreciation		5,064,898	4,617,513
Property, plant, and equipment, net		4,805,640	4,573,841
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Total cost		$ 6,796,617	5,879,958
Machinery and Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful life		5 years
Machinery and Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful life		10 years
Building and Improvements [Member]
Property, Plant and Equipment [Line Items]
Total cost		$ 1,923,027	1,923,027
Property and equipment, estimated useful life		39 years
Land [Member]
Property, Plant and Equipment [Line Items]
Total cost		$ 185,000	185,000
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Total cost	[1]	$ 722,984	722,984
Leasehold Improvements [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful life		3 years
Leasehold Improvements [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful life		10 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Total cost		$ 71,903	68,272
Property and equipment, estimated useful life		7 years
Software and Websites [Member]
Property, Plant and Equipment [Line Items]
Total cost		$ 171,007	$ 412,113
Property and equipment, estimated useful life		3 years
[1]	Expected lease term between 3 and 10 years.

Property Plant and Equipment 37

Property Plant and Equipment - Schedule of Property, Plant and Equipment (Details) (Parenthetical) - Leasehold Improvements [Member]	12 Months Ended
	Dec. 31, 2017
Minimum [Member]
Property and equipment, estimated useful life	3 years
Maximum [Member]
Property and equipment, estimated useful life	10 years

Intangible Assets and Goodwil38

Intangible Assets and Goodwill (Details Narrative) - USD ($)	Nov. 10, 2016	May 31, 2017	Dec. 31, 2017	Dec. 31, 2016
Goodwill [Line Items]
Patent prosecution costs			$ 12,000	$ 74,000
Payments to acquire intangible assets			11,552	73,661
Proceeds from sale of intangible assets		$ 495,000		495,000
Amortization of intangibles			$ 687,000	$ 700,000
Intellectual Discovery Co Ltd [Member]
Goodwill [Line Items]
Payments to acquire intangible assets	$ 3,000,000

Intangible Assets and Goodwil39

Intangible Assets and Goodwill - Schedule of Intangible Assets (Details) - USD ($)		12 Months Ended
		Dec. 31, 2017	Dec. 31, 2016
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		$ 6,300,317	$ 6,288,765
Accumulated Amortization		5,079,565	4,392,747
Net Carrying Amount		1,220,752	1,896,018
Customer Lists and Non-compete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		1,997,300	1,997,300
Accumulated Amortization		1,810,750	1,721,357
Net Carrying Amount		$ 186,550	275,943
Customer Lists and Non-compete Agreements [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life		5 years
Customer Lists and Non-compete Agreements [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life		10 years
Patents and Patent Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Useful life, description	[1]	Varied
Gross Carrying Amount		$ 3,155,000	3,155,000
Accumulated Amortization		2,603,942	2,092,767
Net Carrying Amount		$ 551,058	1,062,233
Patent Application Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Useful life, description	[2]	Varied
Gross Carrying Amount		$ 1,148,017	1,136,465
Accumulated Amortization		664,873	578,623
Net Carrying Amount		$ 483,144	$ 557,842
[1]	Acquired patents and patent rights are amortized over their expected useful life which is generally the remaining legal life of the patent. As of December 31, 2017, the weighted average remaining useful life of these assets in service was approximately 1.7 years.
[2]	Patent application costs are amortized over their expected useful life which is generally the remaining legal life of the patent. As of December 31, 2017, the weighted average remaining useful life of these assets in service was approximately 6.3 years.

Intangible Assets and Goodwil40

Intangible Assets and Goodwill - Schedule of Intangible Assets (Details) (Parenthetical)	12 Months Ended
	Dec. 31, 2017
Patents and Patent Rights [Member]
Weighted average remaining useful life	1 year 8 months 12 days
Patent Application Costs [Member]
Weighted average remaining useful life	6 years 3 months 19 days

Intangible Assets and Goodwil41

Intangible Assets and Goodwill - Schedule of Estimated Future Amortization of Intangible Assets (Details)	Dec. 31, 2017USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2,018	$ 542,089
2,019	277,570
2,020	183,606
2,021	81,731
2,022	$ 80,102

Intangible Assets and Goodwil42

Intangible Assets and Goodwill - Schedule of Changes on Carrying Amount of Goodwill (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Goodwill [Line Items]
Goodwill, net, Beginning balance	$ 2,453,349	$ 2,453,349
Accumulated impairment losses, Beginning balance
Goodwill, Beginning balance	2,453,349	2,453,349
Goodwill acquired during the year
Impairment losses
Goodwill, net, Ending balance	2,453,597	2,453,349
Accumulated impairment losses, Ending balance
Goodwill, Ending balance	2,453,597	2,453,349
Packaging [Member]
Goodwill [Line Items]
Goodwill, net, Beginning balance	1,768,400	1,768,400
Accumulated impairment losses, Beginning balance
Goodwill, Beginning balance	1,768,400	1,768,400
Goodwill acquired during the year
Impairment losses
Goodwill, net, Ending balance	1,768,648	1,768,400
Accumulated impairment losses, Ending balance
Goodwill, Ending balance	1,768,648	1,768,400
Plastics [Member]
Goodwill [Line Items]
Goodwill, net, Beginning balance	684,949	684,949
Accumulated impairment losses, Beginning balance
Goodwill, Beginning balance	684,949	684,949
Goodwill acquired during the year
Impairment losses
Goodwill, net, Ending balance	684,949	684,949
Accumulated impairment losses, Ending balance
Goodwill, Ending balance	$ 684,949	$ 684,949

Short-Term and Long-Term Debt (

Short-Term and Long-Term Debt (Details Narrative) - USD ($)

Dec. 02, 2017

Sep. 07, 2017

Feb. 23, 2017

Dec. 29, 2016

Sep. 20, 2016

May 23, 2016

Apr. 12, 2016

Apr. 28, 2015

Feb. 23, 2015

Sep. 05, 2014

Feb. 13, 2014

Jul. 19, 2013

May 24, 2013

May 31, 2017

May 31, 2014

May 24, 2013

Dec. 30, 2011

Aug. 30, 2011

Dec. 31, 2017

Dec. 31, 2016

Jul. 26, 2017

Mar. 27, 2014

Dec. 06, 2013

Debt Instrument [Line Items]

Stock options issued, exercise price per share

$ 1

Fair value of warrants

$ 112,000

$ 87,000

Sale of investment units, warrant exercise price per share

$ 1

Long-term debt, net

$ 1,734,171

$ 5,249,569

Proceeds from sale of intangible assets

$ 495,000

495,000

Short-term debt

3,645,760

Accrued interest

281,500

Unamortized debt issuance costs

29,994

Convertible Notes Payable [Member]

Debt Instrument [Line Items]

Debt instrument, maturity date

Dec. 29, 2013

Debt instrument, face amount

$ 575,000

Debt interest rate

10.00%

10.00%

10.00%

Beneficial conversion feature recorded as a debt discount

$ 88,000

Debt instrument maturity date, description

December 29, 2013 to December 29, 2015

Debt instrument, carrying amount

$ 650,000

$ 650,000

50,000

230,000

Promissory Notes 1 [Member]

Debt Instrument [Line Items]

Debt instrument, maturity date

May 31, 2017

Dec. 30, 2016

Dec. 31, 2018

Debt instrument, face amount

$ 850,000

$ 850,000

Debt interest rate

9.00%

9.00%

Debt instrument maturity date, description

May 2, 2014 to May 24, 2015

Periodic installments amount

$ 15,000

Debt instrument, final balloon payment

$ 430,000

$ 230,000

Number of stock issued for exchange consideration

18,000

Number of stock issued for exchange consideration, value

$ 17,640

Shares to be issued upon conversion of convertible note, shares

60,000

60,000

Stock options issued, exercise price per share

$ 3

Fair value of warrants

$ 69,000

Expected volatility

60.00%

Risk-free interest rate per annum

0.89%

Expected dividend yield

0.00%

Long-term debt, unamortized discount

$ 69,000

$ 69,000

Warrant term

5 years

Promissory Notes [Member]

Debt Instrument [Line Items]

Debt instrument, maturity date

May 31, 2017

Apr. 30, 2018

Aug. 31, 2021

Debt instrument, carrying amount

$ 325,000

505,000

Debt instrument, final balloon payment

$ 155,000

Number of stock issued for exchange consideration

18,000

Number of stock issued for exchange consideration, value

$ 17,640

Purchase price for Real Estate acquired

$ 1,500,000

Purchase price for Real Estate acquired, loan obtained

$ 1,200,000

Promissory Notes 2 [Member]

Debt Instrument [Line Items]

Debt instrument, maturity date

May 31, 2016

Debt instrument, final balloon payment

$ 610,000

Fair value of warrants

$ 29,000

Expected volatility

70.00%

Risk-free interest rate per annum

1.53%

Expected dividend yield

0.00%

Long-term debt, unamortized discount

$ 29,000

$ 29,000

Sale of investment units, shares issuable per warrant

40,000

40,000

Sale of investment units, warrant exercise price per share

$ 1.50

$ 1.50

Interest accrued in the period

$ 15,000

Term Loan [Member]

Debt Instrument [Line Items]

Debt instrument, carrying amount

$ 1,303,900

Debt instrument, term

60 months

Interest rate on outstanding term loan

4.84%

Credit facility agreement, monthly principal payment

$ 24,511

Non Revolving Line of Credit Agreement [Member] | Citizens Bank [Member]

Debt Instrument [Line Items]

Line of credit, maximum borrowing amount

$ 800,000

$ 1,200,000

Interest rate additional rate above LIBOR

2.00%

3.44%

Credit facility, amount outstanding

$ 522,000

$ 0

Debt interest rate

2.00%

RBS Citizens [Member]

Debt Instrument [Line Items]

Line of credit, maximum borrowing amount

$ 800,000

Interest rate additional rate above LIBOR

5.12%

Debt instrument, maturity date

May 31, 2018

Credit facility, amount outstanding

$ 0

0

RBS Citizens [Member] | Promissory Notes [Member]

Debt Instrument [Line Items]

Debt interest rate

5.87%

Debt instrument, carrying amount

$ 915,107

966,786

RBS Citizens [Member] | Permanent Loan [Member]

Debt Instrument [Line Items]

Debt instrument, carrying amount

$ 345,000

375,000

$ 450,000

Debt instrument, final balloon payment

$ 300,000

RBS Citizens [Member] | LIBOR [Member]

Debt Instrument [Line Items]

Interest rate additional rate above LIBOR

3.75%

RBS Citizens [Member] | LIBOR [Member] | Promissory Notes [Member]

Debt Instrument [Line Items]

Interest rate additional rate above LIBOR

3.15%

4.51%

Periodic installments amount

$ 7,658

RBS Citizens [Member] | LIBOR [Member] | Permanent Loan [Member]

Debt Instrument [Line Items]

Interest rate additional rate above LIBOR

3.15%

4.52%

Debt instrument, maturity date

Jul. 31, 2019

Periodic installments amount

$ 450,000

Interest accrued in the period

$ 2,500

Debt instrument, term

5 years

People's Capital Leasing Corp [Member] | Term Loan [Member]

Debt Instrument [Line Items]

Debt instrument, carrying amount

$ 286,560

559,609

Citizens [Member] | Term Loan [Member]

Debt Instrument [Line Items]

Debt instrument, carrying amount

$ 525,000

$ 257,007

$ 360,611

Debt instrument, term

60 months

Interest rate on outstanding term loan

3.62%

Credit facility agreement, monthly principal payment

$ 9,591

DSS Technology Management [Member]

Debt Instrument [Line Items]

Debt instrument, maturity date

Feb. 13, 2018

Repayment of shot term debt

$ 770,250

Short-term debt

3,702,129

Fixed and contingent equity interests

$ 459,000

DSS Technology Management [Member] | Investment Agreement [Member]

Debt Instrument [Line Items]

Debt instrument, carrying amount

$ 1,000,000

Advances

$ 4,500,000

Long-term debt, net

$ 1,350,000

1,791,000

900,000

Fixed return equity interests

150,000

199,000

$ 100,000

Fair value of contingent consideration

10,000

Proceeds from return received

$ 1,500,000

2,000,000

Proceeds from sale of intangible assets

$ 125,250

$ 495,000

Payment of obligation

$ 150,000

Straight line basis maturity date

Feb. 13, 2018

Received percentage

25.00%

DSS Technology Management [Member] | Investment Agreement [Member] | March 2, 2017 [Member]

Debt Instrument [Line Items]

Deposits

$ 300,000

DSS Technology Management [Member] | Investment Agreement [Member] | March 2, 2018 [Member]

Debt Instrument [Line Items]

Deposits

$ 300,000

Short Term and Long Term Debt -

Short Term and Long Term Debt - Schedule of Notes Payable and Long-Term Debt (Details)	Dec. 31, 2017USD ($)
Debt Disclosure [Abstract]
2,018	$ 966,506
2,019	596,018
2,020	209,528
2,021	824,226
2,022	104,400
Total	$ 2,700,678

Other Liabilities (Details Narr

Other Liabilities (Details Narrative) - USD ($)	Nov. 14, 2016	Sep. 05, 2014	Mar. 27, 2014	Feb. 13, 2014	Jul. 08, 2013	May 31, 2017	Jul. 31, 2017	Dec. 31, 2017	Dec. 31, 2016
Payment to acquire intangible assets								$ 11,552	$ 73,661
Intangible assets book value								6,300,317	6,288,765
Proceeds from financing amount						$ 495,000			495,000
Other liabilities short term								2,953,629	2,996,310
Payment of estimated future inter parts review costs								30,000
Selling, general and administrative costs								6,465,016	7,326,063
Reduction of the liability								732,500
LED Patent Portfolio [Member]
Selling, general and administrative costs								80,000
DSS Technology Management [Member]
Payment to acquire intangible assets					$ 500,000
Proceeds from financing amount					250,000
Payment milestones amount					$ 750,000
Milestones description					Subject to certain payment milestones, in exchange for 40% of the proceeds which it receives, if any, from the use, sale or licensing of the two patents.
Reduction the liability pays legal and other expense percentage					50.00%
Proceeds Investment Agreement [Member] | Brickell Key Investments LP [Member]
Finance amount	$ 13,500,000
Other liabilities								3,447,000
Other liabilities short term								2,062,500
Payment of estimated future inter parts review costs								2,500,000
Payment of related party cost								1,500,000
Allocation to working capital								1,997,000
Selling, general and administrative costs							$ 47,500
Proceeds Investment Agreement [Member] | Intellectual Discovery Co. Ltd [Member] | LED Patent Portfolio [Member]
Payment to acquire intangible assets	3,000,000
Intangible assets book value	0
Attorneys' fees and out-of-pocket expenses	6,000,000
Proceeds from financing amount	$ 4,500,000
Proceed Right Agreement [Member] | Investors [Member]
Other liabilities								432,000	467,000
Proceeds from related party debt								650,000	$ 650,000
Investment Agreement [Member] | DSS Technology Management [Member]
Proceeds from related party debt		$ 1,500,000	$ 1,000,000	$ 4,500,000
Proceeds from issued and sold promissory note		1,350,000	900,000	1,791,000
Fixed return equity interests				199,000
Contingent equity interests				$ 10,000
Fixed and contingent equity interests		$ 150,000	$ 100,000					$ 495,000
Liabilities maturity date								Feb. 13, 2018

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)	Nov. 02, 2017	Sep. 12, 2017	Sep. 07, 2017	Aug. 30, 2017	Jan. 12, 2017	Dec. 29, 2016	Nov. 29, 2016	Aug. 26, 2016	Jun. 20, 2013	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2017	Dec. 31, 2016
Reverse stock split								one-for-four reverse stock split
Number of shares of common stock sold						300,000
Warrant exercise price per shares						$ 1
Stock option issued value													$ 1,842,778	$ 199,908
Proceeds from sale of stock													$ 951,118	$ 199,908
Fair value of warrant			$ 112,000			$ 87,000
Volatility			89.30%			86.40%							72.60%	85.60%
Risk free return			1.70%			1.96%							1.70%	1.30%
Dividend yield			0.00%			0.00%							0.00%	0.00%
Investment costs											$ 485,000		$ 485,000
Stock based compensation													$ 214,862	$ 328,567
Stock options issued, exercise price per share														$ 1
Number of restricted common stock issued											50,000
Stock compensation expense													$ 215,000	$ 329,000
Stock compensation expense, description													the Company had stock compensation expense of approximately $215,000 or $0.01 basic earnings per share ($329,000; $0.03 basic earnings per share - 2016)
Basic and diluted earnings per share													$ 0.04	$ 0.07
Unrecognized compensation costs											$ 1,700		$ 1,700
Restricted Stock [Member]
Number of restricted common stock issued					150,000									224,750
Restricted shares vested date					May 17, 2017									May 17, 2017
Restricted stock, value					$ 126,000									$ 124,000
Sale of Equity [Member]
Listing fees														$ 25,000
Stock Warrants [Member]
Warrant term							5 years
Warrant exercise price per shares						$ 1	$ 1
Fair value of warrant							$ 199,000
Volatility							86.40%
Risk free return							1.78%
Dividend yield							0.00%
Proceeds from exercise of warrants													$ 336,000
Warrant to shares of common stock							750,000				394,091		394,091
Stock based compensation												$ 198,000
Warrant [Member]
Warrant term						5 years
Stock options issued, exercise price per share													$ 1	$ 1
Stock Options [Member]
Stock based compensation										$ 36,000
Stock options issued
Weighted-average grant date fair value of options granted														$ 0.10
Fair value of options vested during the year										$ 41,667			$ 417	$ 71,000
Number of option cancelled										75,000
Stock options issued, exercise price per share										$ 12
Stock Options [Member] | 2013 Plan [Member]
Stock options issued									1,500,000
EBITDA [Member] | Restricted Stock [Member]
Restricted stock, value											$ 500,000
Sale of stock price per share					$ 1						$ 1		$ 1
Maximum [Member]
Warrant to purchase of common shares						200,000
Maximum [Member] | Stock Warrants [Member]
Warrant to purchase of common shares						200,000
Securities Purchase Agreement [Member]
Warrant purchase price						$ 225,000
Management Team [Member] | Restricted Stock [Member]
Number of restricted common stock issued					100,000
Hengfai Business Development Pte Ltd. [Member] | Securities Exchange Agreement [Member]
Warrant term		3 years
Agent fees and stock listing fees		$ 13,660
Sale of investment value		$ 484,930											$ 900,112
Sale of investment shares		683,000
Exchange for ordinary shares		21,196,552
Singapore eDevelopment Limited [Member] | Securities Exchange Agreement [Member]
Warrant exercise price per shares		$ 0.0298
Singapore eDevelopment Limited [Member] | Securities Exchange Agreement [Member] | Singapore, Dollars [Member]
Warrant exercise price per shares		$ 0.040
Singapore eDevelopment Limited [Member] | Securities Exchange Agreement [Member] | Maximum [Member]
Warrant to purchase of common shares		105,982,759
Two Related Party Investors [Member]
Number of shares of common stock sold			133,333
Warrant term			5 years
Warrant to purchase of common shares			26,667
Warrant exercise price per shares			$ 1
Stock option issued value			$ 100,000
Agent fees and stock listing fees			$ 62,000
Two Related Party Investors [Member] | Unregistered Common Stock [Member]
Number of shares of common stock sold				1,200,000
Warrant term				5 years
Warrant to purchase of common shares				240,000
Warrant exercise price per shares				$ 1
Stock option issued value				$ 900,000
Proceeds from sale of stock				$ 300,000
Nix, Patterson & Roach LLP [Member]
Number of shares of common stock sold	500,000
Warrant term	3 years
Warrant exercise price per shares	$ 1
Stock option issued value	$ 125,000
Fair value of warrant	$ 40,000
Volatility	89.10%
Risk free return	2.00%
Dividend yield	0.00%
Litigation settling expenses	$ 714,000
General and administrative expense	495,000
Nix, Patterson & Roach LLP [Member] | Reduction [Member]
General and administrative expense	$ 219,000
Nix, Patterson & Roach LLP [Member] | Maximum [Member]
Warrant to purchase of common shares	125,000
Marketing Services [Member] | Restricted Stock [Member]
Number of restricted common stock issued														6,250
Restricted shares vested date														May 2, 2016
Restricted stock, value														$ 6,250

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Warrant Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Outstanding, Beginning balance	635,597	1,106,140
Granted during the year		37,500
Outstanding, Ending balance	482,667	635,597
Outstanding Beginning balance, Weighted Average Exercise Price	$ 9.33	$ 11.56
Granted, Weighted Average Exercise Price		1
Outstanding, Ending balance, Weighted Average Exercise Price	10.72	9.33
Exercisable Weighted Average Exercise Price	$ 9.29	$ 10.85
Warrant [Member]
Outstanding, Beginning balance	2,812,515	1,862,515
Granted during the year	391,667	950,000
Exercised/lapsed/terminated	(559,092)
Outstanding, Ending balance	2,645,090	2,812,515
Exercisable, Ending balance	2,645,090	2,812,515
Outstanding Beginning balance, Weighted Average Exercise Price	$ 11.20	$ 16.40
Granted, Weighted Average Exercise Price	1	1
Exercised/lapsed/terminated Weighted Average Exercise Price	5.11
Outstanding, Ending balance, Weighted Average Exercise Price	10.98	11.20
Exercisable Weighted Average Exercise Price	10.98	11.20
Weighted average months remaining	$ 24.3	$ 34.6

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Stock Option Activity Under Stock Option and Incentive Plans (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Equity [Abstract]
Outstanding, Beginning balance	635,597	1,106,140
Granted		37,500
Lapsed/terminated	(152,930)	(508,043)
Outstanding, Ending balance	482,667	635,597
Exercisable	478,500	610,611
Expected to vest , Ending balance	4,167	25,000
Outstanding Beginning balance, Weighted Average Exercise Price	$ 9.33	$ 11.56
Granted, Weighted Average Exercise Price		1
Lapsed/terminated, Weighted Average Exercise Price	9.67	13.56
Outstanding, Ending balance, Weighted Average Exercise Price	10.72	9.33
Exercisable Weighted Average Exercise Price	9.29	10.85
Expected to Vest, Ending balance, Weighted Average Exercise Price	$ 1	$ 1
Oustanding, Weighted Average Life Remaining	3 years 3 months 19 days	3 years 8 months 12 days
Exercisable, Weighted Average Life Remaining	3 years 3 months 19 days	3 years 8 months 12 days
Expected to vest, Weighted Average Life Remaining	3 years 3 months 19 days	4 years 3 months 19 days
Aggregate intrinsic value of outstanding option, Ending balance	$ 10,000
Aggregate intrinsic value of exercisable options, Ending balance	6,667
Aggregate intrinsic value of options expected to vest, Ending balance	$ 3,333

Stockholders' Equity - Schedu49

Stockholders' Equity - Schedule of Assumptions Used to Compute the Share-based Compensation Expense for Stock Options and Warrants (Details)	Sep. 07, 2017	Dec. 29, 2016	Dec. 31, 2017	Dec. 31, 2016
Equity [Abstract]
Volatility	89.30%	86.40%	72.60%	85.60%
Expected option term				3 years 6 months
Risk-free interest rate	1.70%	1.96%	1.70%	1.30%
Expected forfeiture rate				0.00%
Expected dividend yield	0.00%	0.00%	0.00%	0.00%

Stockholders' Equity - Summar50

Stockholders' Equity - Summary of Restricted Stock (Details) - Restricted Stock [Member] - $ / shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Restricted shares outstanding, Beginning balance, Shares	231,000	15,000
Restricted shares granted, Shares	150,000	231,000
Restricted shares vested, Shares	(331,000)	(15,000)
Restricted shares outstanding, Ending balance, Shares	50,000	231,000
Restricted shares outstanding, Beginning balance, Weighted-average Grant Date Fair Value	$ 0.56	$ 0.88
Restricted shares granted, Weighted-average Grant Date Fair Value	0.84	0.56
Restricted shares vested, Weighted-average Grant Date Fair Value	0.64	0.88
Restricted shares outstanding, Ending balance, Weighted-average Grant Date Fair Value	$ 0.64	$ 0.56

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	Dec. 22, 2017	Dec. 31, 2017	Dec. 31, 2016
Federal income tax percentage		34.00%	34.00%
Effective income tax percentage	11.50%	3.60%	(1.10%)
Net, deffered tax liability	$ 68,818
Deferred tax assets		$ 93,201
Deferred tax assets receivable current		46,600
Deferred tax assets receivable noncurrent		$ 46,601
Net operating loss carryforwards, expiration date		2022 through 2036
Deferred tax assets valuation allowance		$ 6,900,000
Foreign [Member]
Net operating loss carryforwards		$ 47,200,000
After December 31, 2017 and Before December 31, 2020 [Member]
Federal tax credit		50.00%
Maximum [Member]
Federal income tax percentage	35.00%
Minimum [Member]
Federal income tax percentage	21.00%

Income Taxes - Schedule of Inco

Income Taxes - Schedule of Income Tax Provision (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Federal, Current	$ (16,694)	$ 132,835
State, Current	8,572	(5,617)
Total currently payable	(8,122)	127,218
Federal, Deferred	(410,402)	(379,710)
State, Deferred	(58,001)	(111,642)
Total deferred	(468,403)	(491,352)
Less: increase in allowance	524,381	374,864
Plus: effect of tax change	(68,818)
Net deferred	(12,840)	(116,488)
Total income tax expense (benefit)	$ (20,962)	$ 10,730

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Deferred tax assets: Net operating loss carryforwards	$ 10,063,436	$ 15,302,177
Deferred tax assets: Equity issued for services	146,029	280,975
Deferred tax assets: Goodwill and other intangibles	997,676	1,684,346
Deferred tax assets: Investment in pass-through entity	11,575	17,898
Deferred tax assets: Deferred revenue	807,959	1,522,258
Deferred tax assets: Other	523,937	849,325
Deferred tax assets: Gross deferred tax assets	12,550,612	19,656,979
Deferred tax liabilities: Goodwill and other intangibles	169,170	277,231
Deferred tax liabilities: Depreciation and amortization	62,288	272,406
Deferred tax liabilities: Gross deferred tax liabilities	231,458	549,637
Deferred tax liabilities: Less: valuation allowance	(12,445,136)	(19,152,961)
Deferred tax liabilities: Net deferred tax liabilities	$ (125,982)	$ (45,619)

Income Taxes - Schedule of Effe

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)	Dec. 22, 2017	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Statutory United States federal rate		34.00%	34.00%
State income taxes net of federal benefit		5.50%	5.00%
Permanent difference		0.80%	(3.90%)
Other			(0.40%)
Tax rate change		11.50%
Change in valuation reserves		(48.20%)	(35.80%)
Effective tax rate	11.50%	3.60%	(1.10%)

Defined Contribution Pension 55

Defined Contribution Pension Plan (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Employee's contribution maximum percentage	50.00%
Employer match percentage	3.00%
Contributions by company	$ 103,000	$ 101,000
Additional Contribution [Member]
Employee's contribution maximum percentage	50.00%
Employer match percentage	3.50%
January 1, 2018 [Member]
Employee's contribution maximum percentage	100.00%
Employer match percentage	1.00%

Commitments and Contingencies56

Commitments and Contingencies (Details Narrative)	12 Months Ended
	Dec. 31, 2017USD ($)ft²
Severance payment amount	$ 735,000
Contingent Payment
Minimum [Member]
Lease equipment term	36 months
Maximum [Member]
Lease equipment term	60 months
Document Security Systems Corporate Offices and Digital Division [Member]
Area of square feet | ft²	5,700
Lease expiration date	Dec. 31, 2020
Rent expense	$ 6,100
Document Security Systems Plastics Group [Member]
Area of square feet | ft²	15,000
Lease expiration date	Dec. 31, 2018
Rent expense	$ 13,000
Packaging and Printing [Member]
Area of square feet | ft²	40,000
Reston Virginia [Member]
Lease expenses, per month	$ 600
DSS Technology Management [Member]
Lease expiration date	Dec. 31, 2017
Paid of rent	$ 1,200
Plano Lease [Member]
Lease expiration date	Dec. 21, 2018
Paid of rent	$ 1,300

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Future Minimum Payments Under Operating Leases (Details)	Dec. 31, 2017USD ($)
Payments made in 2017	$ 303,516
2,018	301,788
2,019	83,239
2,020	68,820
Total	453,847
Total future minimum lease commitments	453,847
Equipment [Member]
Payments made in 2017	44,131
2,018	43,258
2,019	14,419
2,020
Total	57,677
Total future minimum lease commitments	57,677
Facilities [Member]
Payments made in 2017	259,385
2,018	258,530
2,019	68,820
2,020	68,820
Total	396,170
Total future minimum lease commitments	$ 396,170

Supplemental Cash Flow Inform58

Supplemental Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Supplemental Cash Flow Information [Abstract]
Cash paid for interest	$ 141,000	$ 210,000
Gain from change in fair value of interest rate swap derivative	22,000	18,000
Capitalized debt modification costs that increase debt balance		150,000
Account payable settled with issuance of equity instruments	370,000
Common stock issued for investment	$ 485,000

Segment Information (Details Na

Segment Information (Details Narrative) - Segment	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Segment Reporting Information [Line Items]
Number of operating segment	4
International Revenue [Member]
Segment Reporting Information [Line Items]
Concentration of credit risk, percentage	3.20%	2.00%

Segment Information - Schedule

Segment Information - Schedule of Operations by Reportable Segment (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Segment Reporting Information [Line Items]
Revenue	$ 18,661,872	$ 19,177,599
Depreciation and amortization	1,413,838	1,391,815
Interest expense	223,321	248,064
Amortized debt discount	154,142	31,150
Stock based compensation	214,862	328,567
Income tax benefit	(20,962)	10,730
Net Income (loss) to common shareholders	(599,118)	(939,273)
Identifiable assets	17,430,777	18,466,023
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue	18,662,000	19,178,000
Depreciation and amortization	1,414,000	1,392,000
Interest expense	223,000	248,000
Amortized debt discount	154,000	31,000
Stock based compensation	215,000	329,000
Income tax benefit	(21,000)	11,000
Net Income (loss) to common shareholders	(578,000)	(950,000)
Capital expenditures	959,000	3,386,000
Identifiable assets	17,431,000	18,466,000
Operating Segments [Member] | Packaging and Printing [Member]
Segment Reporting Information [Line Items]
Revenue	12,556,000	12,934,000
Depreciation and amortization	663,000	617,000
Interest expense	107,000	121,000
Amortized debt discount	1,000	2,000
Stock based compensation		17,000
Income tax benefit
Net Income (loss) to common shareholders	1,453,000	1,533,000
Capital expenditures	439,000	251,000
Identifiable assets	9,331,000	9,484,000
Operating Segments [Member] | Plastics [Member]
Segment Reporting Information [Line Items]
Revenue	4,470,000	4,344,000
Depreciation and amortization	134,000	122,000
Interest expense
Amortized debt discount
Stock based compensation		10,000
Income tax benefit
Net Income (loss) to common shareholders	385,000	447,000
Capital expenditures	520,000	18,000
Identifiable assets	2,933,000	2,335,000
Operating Segments [Member] | Technology [Member]
Segment Reporting Information [Line Items]
Revenue	1,636,000	1,900,000
Depreciation and amortization	614,000	649,000
Interest expense	62,000	41,000
Amortized debt discount	131,000	29,000
Stock based compensation	40,000	26,000
Income tax benefit
Net Income (loss) to common shareholders	(1,219,000)	(1,271,000)
Capital expenditures		3,117,000
Identifiable assets	1,725,000	1,942,000
Operating Segments [Member] | Corporate [Member]
Segment Reporting Information [Line Items]
Revenue
Depreciation and amortization	3,000	4,000
Interest expense	54,000	86,000
Amortized debt discount	22,000
Stock based compensation	175,000	276,000
Income tax benefit	(21,000)	11,000
Net Income (loss) to common shareholders	(1,197,000)	(1,659,000)
Capital expenditures
Identifiable assets	$ 3,442,000	$ 4,705,000